Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7786072309149135,-2.2778646026540814,0.0,0.0,0.0,9/22,13.51%,ALDH1A2;PTGDS;NR2F2;ABCA4;RBP4;RXRA;RBP1;RARA;CYP26B1
prerank,retinoic acid binding (GO:0001972),-0.815964864932825,-2.0006861176749706,0.0,0.012879108477923543,0.021,4/12,13.51%,NR2F2;RXRA;RARA;CYP26B1
prerank,cation channel activity (GO:0005261),-0.49234952695916456,-1.9998501235669046,0.0,0.008586072318615696,0.021,42/94,28.98%,TRPM3;SLC24A3;HCN1;NALCN;MCU;CACNA1D;PKD1;UNC80;ANXA2;TRPM6;TRPC5;SEC61A1;PIEZO2;KCNK5;TRPC1;KCNA1;SLC24A2;ANO1;KCNK10;TMEM63A;ABCC9;TMCO1;ANO6;TMEM63B;TMEM38A;KCNQ4;ANO10;KCNA2;GRIN1;TRPC6;MCOLN1;ANXA6;PANX1;CALHM5;KCNK9;CHRNA7;TRPV2;SLC24A4;KCNK1;TRPC3;TMEM63C;CACNA1E
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.5417820721017359,-1.9743338466548173,0.0,0.009366624347580758,0.031,23/60,10.93%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;NRP1;AXL;RYK;EPHA7;ROR1;EFEMP1;KIT;CRIM1;DDR1;PDGFRA;EPHB4;NRP2;EPHB2;EPHA3;IGF2R
prerank,voltage-gated cation channel activity (GO:0022843),-0.4769768122032659,-1.959005322269213,0.0,0.00913245873889124,0.037,40/97,28.98%,CACNA2D3;KCNQ3;KCNB2;CACNA1C;HCN1;KCNH7;KCNQ5;KCNMA1;CACNA1D;CACNB4;GRIN2B;KCNC2;KCND2;CACNA1B;KCNH5;KCNA1;CACNG7;CACNG4;KCNS3;OPRM1;KCNQ4;CACNG2;NCS1;KCNA6;KCNA2;GRIN2D;GRIN1;CACNA2D1;KCNC1;CACNG3;CACNG8;CACNB1;KCNC3;HCN2;KCNQ1;CACNA2D2;KCNQ2;KCNK1;LRRC38;CACNA1E
prerank,platelet-derived growth factor binding (GO:0048407),-0.8239077257645482,-1.955481347969316,0.0,0.008000658296891899,0.038,7/11,6.19%,COL1A2;COL1A1;PDGFRB;COL3A1;COL5A1;COL6A1;PDGFRA
prerank,nucleotidyltransferase activity (GO:0016779),0.6898867885503103,1.8119692155469354,0.0036231884057971015,0.6617146082858826,0.487,9/19,15.07%,THG1L;MOCS3;NUDT5;TENT4A;TERT;CRPPA;TUT7;PAPSS1;TUT4
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.5593248323693514,-1.7737614875661163,0.004975124378109453,0.12845656248110757,0.492,13/32,28.09%,KCNQ3;KCNB2;KCNQ5;KCNC2;KCNA1;KCNS3;KCNQ4;KCNA6;KCNA2;KCNC1;KCNC3;KCNQ1;KCNQ2
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.48219174959421873,-1.7620678447865137,0.0,0.1317181548878544,0.548,21/60,12.18%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;TGFBR2;AXL;RYK;EPHA7;ROR1;KIT;DDR1;PDGFRA;EPHB4;ACVR1;EPHB2;EPHA3;ACVR1B
prerank,glycine binding (GO:0016594),-0.7192605945450805,-1.7575349557577278,0.004246284501061571,0.12540869265372015,0.574,5/11,7.73%,GRIN2B;GLRB;SRR;GLRA3;GLRA1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6887873374546605,1.7300774111740946,0.0037174721189591076,0.6062045945415276,0.821,7/16,6.45%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6887873374546605,1.7300774111740946,0.0037174721189591076,0.6062045945415276,0.821,7/16,6.45%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,organic cation transmembrane transporter activity (GO:0015101),0.6704712029506037,1.6979613439426238,0.003745318352059925,0.6537846063224033,0.91,4/16,7.94%,SLC5A7;SLC7A8;SLC44A1;SLC25A26
prerank,voltage-gated potassium channel activity (GO:0005249),-0.4380457436521618,-1.690294758597894,0.002849002849002849,0.24119057695020454,0.826,28/80,29.45%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNJ2;KCNA1;KCNJ6;KCNJ13;KCNS3;KCNQ4;KCNJ10;KCNA6;KCNA2;KCNT1;KCNC1;KCNC3;HCN2;KCNQ1;KCNQ2;KCNK1;LRRC38;KCNJ12
prerank,metalloendopeptidase activity (GO:0004222),-0.4319466777474271,-1.6752872837298844,0.0,0.25438900216725013,0.865,28/76,20.62%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;MMP16;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;ADAM19;ADAMTS5;NLN;ADAMTS1;ADAMTSL4;ADAMTS3;AFG3L2;ADAMTS10;MBTPS2;PITRM1;ADAMTS15;ADAMTS16;SPG7;MMP2;ADAM33;ADAMTS20
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7231556778062536,1.673435144745091,0.019305019305019305,0.6682348321225212,0.96,9/12,16.46%,CNOT2;CNOT7;PAN3;PAN2;CNOT6;CNOT1;CNOT6L;NOCT;PARN
prerank,wide pore channel activity (GO:0022829),-0.5675570312679823,-1.664951260851235,0.011337868480725623,0.2585578595946772,0.891,5/23,11.16%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,calcium channel activity (GO:0005262),-0.4207373340117264,-1.6625843639903273,0.0,0.24488318847184695,0.899,36/84,28.98%,CACNA2D3;SLC24A3;CACNA1C;STIM2;MCU;CACNA1D;CACNB4;PKD1;ANXA2;TRPC5;P2RX4;SEC61A1;CACNA1B;TRPC1;SLC24A2;CACNG7;TMCO1;CACNG4;OPRM1;CACNG2;NCS1;GRIN1;CACNA2D1;TRPC6;MCOLN1;ANXA6;PANX1;CACNG3;CACNG8;CACNB1;CHRNA7;TRPV2;SLC24A4;CACNA2D2;TRPC3;CACNA1E
prerank,gap junction channel activity (GO:0005243),-0.5739749971683692,-1.6622041307539497,0.013636363636363636,0.22814420732321708,0.9,5/22,11.16%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,solute:anion antiporter activity (GO:0140323),-0.6421159011064712,-1.6595027830298346,0.01182033096926714,0.21871067851601073,0.904,6/14,20.03%,SLC7A11;SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC4A3
prerank,monocarboxylic acid binding (GO:0033293),-0.5936608556011851,-1.6473012037126884,0.016317016317016316,0.2285309987304274,0.927,6/18,13.51%,NR2F2;PSAP;NAPEPLD;RXRA;RARA;CYP26B1
prerank,solute:sodium symporter activity (GO:0015370),0.6054197762921036,1.6430294616223695,0.013961605584642234,0.7465949996727534,0.983,3/27,0.83%,SLC5A7;SLC4A4;SLC4A5
prerank,potassium channel regulator activity (GO:0015459),-0.4590698824111077,-1.6392721243478072,0.0,0.23265041945682208,0.943,15/49,13.20%,DPP6;KCNIP4;KCNIP1;WNK1;FLNA;KCNIP3;ENSA;AKAP9;ARPP19;WNK4;SGK1;DPP10;ABCC9;DLG1;WNK3
prerank,R-SMAD binding (GO:0070412),-0.5945148819715863,-1.6338180127997124,0.01978021978021978,0.23052303255434867,0.95,7/18,12.12%,DDX5;LDLRAD4;SMAD3;SMAD4;SMAD6;RANBP3;PPM1A
prerank,MAP-kinase scaffold activity (GO:0005078),-0.690236219533955,-1.6301130505578525,0.01279317697228145,0.22529196457075826,0.956,4/11,8.30%,AKAP13;KSR1;IQGAP1;MAP2K2
prerank,alanine transmembrane transporter activity (GO:0022858),0.7022408101082114,1.6224653971569718,0.027675276752767528,0.7700913017867661,0.991,4/12,5.53%,SLC7A8;SLC36A4;SLC3A2;SLC6A6
prerank,leak channel activity (GO:0022840),-0.5822639150750928,-1.6153457854441289,0.024336283185840708,0.24429327126534067,0.97,4/18,10.34%,KCNK2;NALCN;KCNK5;KCNK10
prerank,estrogen receptor binding (GO:0030331),0.5489830472474346,1.6049743336916305,0.019966722129783693,0.7902467234439428,0.996,11/32,10.52%,DCAF1;ARID5A;LEF1;DDX54;RERG;SRARP;CCDC62;PHB2;WBP2;ESR1;TACC1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5948169905241483,-1.5994950530546512,0.017278617710583154,0.26823112938220856,0.981,7/18,16.88%,PDLIM5;ANXA2;ANXA1;BAIAP2L1;PDLIM1;S100A11;CDC42EP1
prerank,acid-thiol ligase activity (GO:0016878),-0.6280901353750343,-1.5968263986268671,0.02575107296137339,0.2616268482540171,0.981,6/13,27.60%,ACSL1;ACSS3;ACSS2;AASDH;AACS;ACSS1
prerank,phosphatase binding (GO:0019902),-0.39056261534849496,-1.596432291205978,0.006644518272425249,0.2512189736701687,0.981,45/105,21.97%,MAGI2;EGFR;SMAD3;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;SYTL2;CTNNB1;WNK1;PXN;VCP;MYO16;CRY2;ELL;STAT6;CDKN1B;DLG3;MAP3K5;TP53;CRY1;IKBKE;KIF3A;SIRPA;VRK3;DLG1;RACK1;PTK2;MTMR9;PPME1;MTMR4;NFATC2;TRAF2;FBXL2;TSC2;SNX3;CNST;SHOC2;MET;PIK3R1;PPP6R3;ITGA1;SH3RF2;PDLIM4
prerank,poly-purine tract binding (GO:0070717),-0.5171409777407989,-1.5963309074419718,0.029197080291970802,0.24089786993934265,0.981,11/27,16.15%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,metallopeptidase activity (GO:0008237),-0.386274525670888,-1.5914088321259052,0.003816793893129771,0.2410500775849908,0.985,37/113,20.76%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;ADAM12;THSD4;ADAM23;MMP16;PAPPA;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;RNPEP;ADAM19;ADAMTS5;ANPEP;NLN;ADAMTS1;ADAMTSL4;ADAMTS3;AFG3L2;ADAMTS10;MBTPS2;LAP3;ACE;PITRM1;ADAMTS15;ADAMTS16;SPG7;MMP2;COPS5;ADAM33;ADAMTS20;MYSM1
prerank,ion channel activity (GO:0005216),-0.40431376519786366,-1.5817868539568647,0.006134969325153374,0.25019694651518604,0.994,33/80,28.80%,TRPM3;GABRB1;NALCN;GRIA4;GRIA2;GRID2;GRIN2B;UNC80;TRPM6;PIEZO2;GRID1;TRPC1;TMEM63A;ABCC9;GRIK4;TMEM63B;TMEM120B;GRIK1;GRIK3;MCUB;GRIN2D;GRIN1;TMEM120A;TRPC6;MCOLN1;ANXA6;CALHM5;CHRNA7;TRPV2;LRRC8A;GRIA1;TMC4;TMC6
prerank,CoA-ligase activity (GO:0016405),-0.5998960914604328,-1.580380803777094,0.017241379310344827,0.24422605706284647,0.995,3/14,6.30%,ACSL1;ACSS3;ACSS2
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.5441776316340101,-1.576056765795833,0.017777777777777778,0.24466124579328136,0.995,8/21,9.54%,ARFGEF2;AKAP6;WASF2;PRRC1;WASF1;AKAP9;EZR;PRKACA
prerank,ATPase activator activity (GO:0001671),-0.5410191455431015,-1.569013715868723,0.024719101123595506,0.25104168186748776,0.995,7/20,9.45%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;DNAJC19;TOR1AIP1;ATP1B2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.45992725670866147,-1.5526737605272056,0.012953367875647668,0.2766276390652184,0.999,16/42,17.33%,LRRC4C;CNTN4;PDLIM5;CNTN6;NTNG1;ANXA2;DSCAM;JAM3;PALLD;ANXA1;BAIAP2L1;SIRPA;PDLIM1;S100A11;CDC42EP1;NEXN
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6576289666613924,-1.5487678967475869,0.02610441767068273,0.2765797987795722,0.999,3/10,7.64%,SLC6A13;SLC6A1;SLC6A12
prerank,poly(A) binding (GO:0008143),-0.5514102583120155,-1.5473016344573043,0.04205607476635514,0.2707539850472563,0.999,7/21,7.46%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.46165760300780545,-1.545970242513402,0.029411764705882353,0.26489097492059827,0.999,15/37,24.83%,CACNA2D3;CACNA1C;CACNA1D;CACNB4;CACNA1B;CACNG7;CACNA1G;CACNG4;OPRM1;CACNG2;NCS1;CACNA2D1;CACNG3;CACNG8;CACNB1
prerank,adenylate cyclase binding (GO:0008179),-0.6769055580758202,-1.5036307823830313,0.037848605577689244,0.3557595446134442,1.0,4/10,2.65%,ADCY5;AKAP6;AKAP12;ADCY2
prerank,deoxyribonuclease activity (GO:0004536),0.617237370584569,1.5030725828511582,0.06390328151986183,1.0,1.0,5/14,5.73%,ZRANB3;NME1;MAP1S;ERCC4;APLF
prerank,RNA polymerase II complex binding (GO:0000993),-0.4594093212061269,-1.4989299162588514,0.03412073490813648,0.35844064244402796,1.0,16/32,27.54%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;BRD4;WDR43;PAF1;SMYD2;RTRAF;PCIF1;GTF2B;ZNF326;SUPT4H1;SCAF1
prerank,potassium:proton antiporter activity (GO:0015386),0.6637219698669651,1.490703267247286,0.060546875,1.0,1.0,3/10,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,GTP binding (GO:0005525),0.39117306240932725,1.487737032124005,0.002554278416347382,1.0,1.0,35/172,12.99%,PCK1;THG1L;RAC2;ARF5;RALB;EEF1A1;RAP2A;ARL5C;ARL4D;RERG;NRAS;TUBB;NME1;GBP3;ATL1;RRAD;RAB7A;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;RHOG;DRG2;GNAI1;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,hexosaminidase activity (GO:0015929),-0.5995209962163424,-1.4834340335246983,0.060851926977687626,0.3892678014451184,1.0,7/12,29.57%,CEMIP;CEMIP2;HEXA;HEXB;HEXD;HYAL1;NAGA
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.47781364985475605,-1.4825096260525787,0.03640776699029126,0.3809304861357337,1.0,13/27,27.17%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANKH;ANO1;SLC39A8;SLC22A6;SLC26A11;SLC5A5;SLC25A30;SLC25A11;LRRC8A
prerank,damaged DNA binding (GO:0003684),0.47820731240248093,1.4793919130224789,0.023923444976076555,1.0,1.0,14/44,13.19%,ERCC3;RAD18;PNKP;ERCC4;RAD1;XRCC1;EP300;TDG;DCLRE1B;CREBBP;APTX;RPS3;NBN;MPG
prerank,phospholipase inhibitor activity (GO:0004859),-0.6259739548674358,-1.4779569097618748,0.05578512396694215,0.3833229391718823,1.0,4/10,12.41%,ANXA2;ANXA4;ANXA1;ANXA5
prerank,translation elongation factor activity (GO:0003746),0.6090699830333608,1.4714618832297954,0.05731225296442688,1.0,1.0,6/14,13.37%,EIF5AL1;EIF5A;EEF1A1;TSFM;GTPBP2;EEF1B2
prerank,cAMP response element binding (GO:0035497),-0.6124744071351711,-1.4617068889490132,0.06584362139917696,0.41672471977169395,1.0,7/10,29.17%,CREB5;ATF7;CREB3L2;E4F1;JUN;CREB3L1;HMGA2
prerank,potassium ion leak channel activity (GO:0022841),-0.5496965278035277,-1.456321131718385,0.07158351409978309,0.4221127803639442,1.0,3/15,10.34%,KCNK2;KCNK5;KCNK10
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6122533074263786,-1.4557294974370878,0.058212058212058215,0.413188072210811,1.0,2/11,1.57%,ITPR1;RYR3
prerank,tRNA binding (GO:0000049),0.46427300326608223,1.4518968735358933,0.05448717948717949,1.0,1.0,11/43,16.28%,THG1L;EEF1A1;EIF2A;FARS2;YARS2;ELP1;TRMT10B;TERT;PTCD1;SSB;NSUN6
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.44936218059192196,-1.451242675231763,0.04834605597964377,0.4155603248493642,1.0,14/34,18.34%,IQGAP1;OGT;ADAP2;ZFYVE16;CYTH3;PLEKHB2;GAB2;HIP1R;FCHSD2;DAPP1;COMMD1;IQGAP2;MYO1B;ARAP3
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6045199231504848,-1.4501846817786064,0.0728744939271255,0.4090274155504598,1.0,2/11,2.09%,KCNK2;KCND2
prerank,ligand-gated anion channel activity (GO:0099095),-0.5320976081534586,-1.449265307621911,0.06108597285067873,0.402206042652509,1.0,11/17,24.45%,GABRB1;GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,metal ion binding (GO:0046872),0.3500984000014773,1.4463207773702833,0.0022026431718061676,1.0,1.0,79/477,13.17%,PCK1;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;THG1L;SPOCK2;EFHD2;LCP1;MAP2K7;GCLC;SNRK;CSGALNACT1;EML1;RAP2A;SLC25A24;OXSR1;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;LTBP4;MEX3B;NUDT5;NME1;NUDT12;ATP2A2;CDH2;ITSN1;ESYT2;MMP12;EFHD1;SDF4;APOE;RASGRP3;CIB1;TDG;RET;SELP;MCTP2;SIK3;CALM3;CDH12;UBA2;RCN2;AIF1L;DXO;EXD2;NIM1K;S100A16;TRPM4;PAPOLA;SRPK2;NLK;MCTP1;PGP;GNAI1;ACER3;PAM;PPP3CA;PRNP;PPP3R1;AGRN;MICU3;ADPRH;LETM1;IDS;SLC25A12;CDH5;MAPK12;HSPE1;RRAGC;GSS
prerank,general transcription initiation factor binding (GO:0140296),0.5196729156026298,1.4430223565474993,0.07407407407407407,1.0,1.0,12/25,15.70%,RUVBL2;PSMC1;DRAP1;RUVBL1;RELA;PSMC2;ESR1;GTF2A2;TBP;THRA;DR1;TAF1
prerank,zinc ion binding (GO:0008270),0.36079470324363694,1.4426540631479023,0.0036144578313253013,1.0,1.0,61/293,15.30%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;LVRN;TRIM28;ARIH1;SOD1;TAB2;SHANK3;MYRIP;DUSP12;TRIM8;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MMP12;MME;QPCTL;HPF1;KDM2A;CHMP1A;ZNF205;BMI1;TET3;ZNF3;TAB3;WDFY1;ESCO1;MDM2;MYCBP2;ZDHHC15;NQO2;RBSN;ACER3;TNKS;PAM;CHD3;HHIP;RNF11;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;PHF8;GCH1;GRIN2A;MT2A;QPCT;CRIP2;S100A13;CLIP1;PTGR2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.6364407802534019,1.4426445571041444,0.08316430020283976,1.0,1.0,4/10,18.78%,NAA25;NAA80;NAA15;NAA50
prerank,chloride channel regulator activity (GO:0017081),-0.5632977001044632,-1.441874971084512,0.057649667405764965,0.4125217473080359,1.0,8/14,26.56%,WNK1;STX8;WNK4;SGK1;WNK3;STX1A;VAMP8;CHRNA7
prerank,phospholipase C activity (GO:0004629),-0.4773700290368569,-1.441332982141574,0.07159904534606205,0.4057173698381448,1.0,10/25,19.67%,PLCE1;PDIA3;EDNRA;PLCD3;CHRM3;PLCB3;PLCH1;PLCL1;PLCD1;BDKRB2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.4365906613202529,-1.4397532933399773,0.043701799485861184,0.40107088296821863,1.0,15/33,26.46%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;SPTY2D1;GTF2B;ERBB2;ZNF326;SUPT4H1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5685500668008706,-1.434100929443807,0.07300884955752213,0.4070090986034702,1.0,10/13,24.45%,GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5079236762693567,-1.4316582080380216,0.0547945205479452,0.40613396437711774,1.0,4/19,4.75%,ITPR1;GRIN2B;RYR3;P2RX4
prerank,potassium channel activity (GO:0005267),-0.36483227898072734,-1.4304378025740043,0.022435897435897436,0.4013598532938355,1.0,23/89,20.97%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNK5;KCNA1;KCNK10;ABCC9;GRIK4;TMEM38A;KCNS3;KCNQ4;KCNA6;KCNA2;GRIK1;GRIK3;KCNT1
prerank,tropomyosin binding (GO:0005523),-0.5449941783943574,-1.4304210391086647,0.06765327695560254,0.3935359670740916,1.0,2/16,2.45%,CALD1;TMOD2
prerank,acetylcholine receptor activity (GO:0015464),0.5306266333031839,1.4275312885388722,0.055944055944055944,1.0,1.0,1/22,0.03%,HRH4
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4574653811755861,-1.423335574866603,0.061381074168797956,0.4034853565111712,1.0,17/29,24.45%,GABRB1;GRIA4;GRIA2;GRID2;GABRA2;GLRA3;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GRIN2D;GABRG1;GABRA1
prerank,neurexin family protein binding (GO:0042043),-0.6190517370541381,-1.4213225399065772,0.06504065040650407,0.4004673730493962,1.0,6/10,25.99%,SYTL2;NLGN2;NLGN1;SYTL5;NLGN3;SYTL4
prerank,protein tyrosine kinase activity (GO:0004713),-0.34931228482152193,-1.4212546644423758,0.022058823529411766,0.39339822259839186,1.0,25/108,11.06%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;JAK1;AXL;RYK;FER;EPHA7;ROR1;KIT;TEC;DDR1;PDGFRA;HIPK3;FRK;EPHB4;EPHB2;CSK;EPHA3;HIPK1
prerank,cysteine-type peptidase activity (GO:0008234),-0.37201592674011763,-1.4210582353587802,0.019498607242339833,0.3867564344246528,1.0,40/73,28.45%,USP40;USP29;CAPN2;MALT1;USP13;PDIA3;USP11;LGMN;OTULIN;CTSO;USP38;USP50;USP34;USP20;USP7;CASP7;USP10;USP1;USP16;CTSZ;USP42;OTULINL;USP5;CASP2;GGH;USP35;USP49;USP2;USP46;CASP9;CASP3;USP24;ATG4D;OTUD7B;CTSK;SFRP1;CTSF;CTSB;CTSC;UCHL1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5688132979641662,-1.4194350935298254,0.09555555555555556,0.38342527658545433,1.0,4/13,4.74%,BMP6;BMP5;BMP7;BMP4
prerank,protease binding (GO:0002020),-0.35120748966797516,-1.4189590891232753,0.02830188679245283,0.3776844778047531,1.0,27/99,12.39%,COL1A2;SLC2A13;TIMP3;COL1A1;CFLAR;TIMP2;NTRK2;COL3A1;PSAP;ANXA2;STIM1;ATP9A;F3;VCP;DPP4;LDLR;ADAMTSL4;CCBE1;BIN1;FAP;DVL3;GSK3B;UBC;FN1;TP53;SRI;ECM1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4796796081513393,1.4146946538963294,0.07455429497568881,1.0,1.0,15/34,16.46%,REXO2;CNOT2;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN3;PAN2;CNOT6;CNOT1;CNOT6L;NOCT;ERI2;PARN
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5869252477606373,-1.4137597525972676,0.05531914893617021,0.38322413063464034,1.0,8/11,32.77%,ITPR1;TRPC5;TRPC1;ITPR2;RPH3A;TRPC6;TRPC3;TRPC7
prerank,pyrophosphatase activity (GO:0016462),0.4446613289030716,1.4065315440829644,0.05186385737439222,1.0,1.0,9/50,10.80%,NUDT14;BNIPL;NUDT11;FITM2;NUDT5;PLPP1;DXO;PRUNE1;DDX3X
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6065806853987114,-1.406371368180026,0.07802874743326489,0.39450951701251163,1.0,4/10,6.12%,CACNA1C;CACNA1D;CACNB4;CACNA1B
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4946506021078502,1.4055040336462423,0.0821917808219178,1.0,1.0,7/27,13.48%,POLR2J;POLR2B;POLR1D;POLR1C;TERT;POLR3F;POLR3B
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5977511156308203,1.4041413422719504,0.09807692307692308,1.0,1.0,1/12,0.99%,GPR52
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.338810968964186,-1.3981727143356597,0.010416666666666666,0.4081701697465557,1.0,34/100,21.98%,PLA2G4A;IQGAP1;OGT;ADAP2;MAPT;WIPI1;SNX21;GAP43;PLEKHA8;CLVS2;ZFYVE16;CYTH3;OSBP;OSBPL5;PLEKHB2;GAB2;HIP1R;RNF34;FCHSD2;DAPP1;COMMD1;IQGAP2;MYO1B;ARAP3;SNX3;ARFIP2;BBS5;SAP30L;SNX11;GSDMD;OSBPL8;ATG2A;SH3PXD2B;RPH3A
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5929678645808095,1.396816549955406,0.10784313725490197,1.0,1.0,3/13,9.94%,EBP;ECH1;IDI1
prerank,BMP receptor binding (GO:0070700),-0.5688162532701283,-1.3966525884433043,0.11038961038961038,0.40524086034932905,1.0,4/12,4.74%,BMP6;BMP5;BMP7;BMP4
prerank,GABA receptor activity (GO:0016917),-0.48397657602572547,-1.3946548267112608,0.06398104265402843,0.40344468258410354,1.0,10/21,24.45%,GABRB1;GABRA2;GABRG2;GABBR2;GABRA5;GABRG3;GABRA4;GPR156;GABRG1;GABRA1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4563519286309039,1.3938750612355268,0.049069373942470386,1.0,1.0,14/37,17.80%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1;HARS2;WARS1;IARS2
prerank,O-acyltransferase activity (GO:0008374),0.4734401205111627,1.391649538267689,0.08904109589041095,1.0,1.0,6/30,7.71%,GPAM;LPCAT2;SOAT1;LPCAT3;GPAT4;MBOAT1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3603286093722018,1.3886934501962933,0.006313131313131313,1.0,1.0,37/196,12.99%,PCK1;THG1L;RAC2;ARF5;RALB;EEF1A1;RAP2A;ARL5C;ARL4D;RERG;RAB5C;NRAS;TUBB;NME1;GBP3;ATL1;RRAD;RAB7A;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;RHOG;DRG2;GNAI1;RAB5B;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,ligand-gated ion channel activity (GO:0015276),-0.43135192227116453,-1.3853551882629929,0.0792838874680307,0.4207547127564055,1.0,5/30,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,glucuronosyltransferase activity (GO:0015020),0.5244239399260413,1.3802505826260933,0.08196721311475409,1.0,1.0,3/19,9.20%,CSGALNACT1;EXT2;B3GAT2
prerank,sodium:proton antiporter activity (GO:0015385),0.5954230154748992,1.3796564231628148,0.10150375939849623,1.0,1.0,3/11,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5753216409450308,1.3794494085044875,0.10131332082551595,1.0,1.0,1/14,0.03%,CAPN8
prerank,glutathione transferase activity (GO:0004364),-0.47078147896981315,-1.379325403205633,0.0776255707762557,0.430151246649739,1.0,14/23,40.23%,GSTT1;GSTZ1;GSTT2;PTGES;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;LANCL1;GSTM5;GSTO1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5067308374643545,-1.3788426392210473,0.09932279909706546,0.41842910698179425,1.0,6/17,10.79%,EPHA6;EPHB1;EPHA7;EPHB4;EPHB2;EPHA3
prerank,ephrin receptor activity (GO:0005003),-0.5067308374643545,-1.3788426392210473,0.09932279909706546,0.41842910698179425,1.0,6/17,10.79%,EPHA6;EPHB1;EPHA7;EPHB4;EPHB2;EPHA3
prerank,ligand-gated channel activity (GO:0022834),-0.4325706351606231,-1.3785437158795992,0.07712082262210797,0.4130401736556321,1.0,5/29,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4871050973375739,1.3778676915026717,0.09278350515463918,1.0,1.0,4/27,2.49%,POLR2J;POLR2B;POLR1D;POLR1C
prerank,dynactin binding (GO:0034452),-0.5609295919526204,-1.37102633393156,0.11983471074380166,0.42451125604706547,1.0,6/12,21.12%,BICD1;MAPT;HTT;GSK3B;BICDL1;SNX6
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.46590009646527214,1.366692943496072,0.08547008547008547,1.0,1.0,10/32,17.98%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6;SFXN1;SLC38A5;SLC25A38;SLC7A5;SLC43A2
prerank,TBP-class protein binding (GO:0017025),0.5111942263556247,1.3660128232817204,0.11090909090909092,1.0,1.0,10/21,15.70%,RUVBL2;PSMC1;DRAP1;RUVBL1;PSMC2;ESR1;GTF2A2;THRA;DR1;TAF1
prerank,poly(U) RNA binding (GO:0008266),-0.47038069867855337,-1.3636184800260904,0.11337868480725624,0.43783878268229404,1.0,7/20,16.15%,RBMS1;HNRNPH1;KHDRBS1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,cell adhesion mediator activity (GO:0098631),-0.4558044836631829,-1.3619954289725682,0.11192214111922141,0.43569856719666283,1.0,7/24,6.72%,LRRC4C;CNTN4;CNTN6;NTNG1;DSCAM;JAM3;PALLD
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.575595061183632,-1.3608309401997944,0.09719222462203024,0.43236535874862664,1.0,1/11,0.75%,HCN1
prerank,GDP binding (GO:0019003),0.41147555943785336,1.3607732906848045,0.06948640483383686,1.0,1.0,20/63,17.51%,RALB;RAP2A;RERG;RAB5C;NRAS;RAB7A;RAB11B;RALA;RAB14;GNAI1;RAB5B;RAB22A;RAP2C;RIT1;RRAGC;MIEF1;ARF6;MRAS;RAB28;RAB27A
prerank,adrenergic receptor binding (GO:0031690),-0.5070684378637826,-1.3536849907614568,0.12757201646090535,0.44413410448112095,1.0,3/16,6.20%,MAGI2;DLG4;ARRDC3
prerank,transition metal ion binding (GO:0046914),0.3296548021623187,1.352226610981828,0.007990867579908675,1.0,1.0,78/397,15.50%,PCK1;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;LVRN;RNF7;TRIM28;ARIH1;GYG1;SOD1;TAB2;SHANK3;MYRIP;DUSP12;TRIM8;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MMP12;MME;QPCTL;FBXL5;HPF1;KDM3A;KDM2A;CHMP1A;ZNF205;PIM1;ISCU;BMI1;TET3;ZNF3;TAB3;WDFY1;SOD2;ESCO1;MDM2;MYCBP2;ZDHHC15;EXD2;PARK7;PAPOLA;NQO2;RBSN;NOS3;ACER3;TNKS;PAM;PRNP;CUTC;MGAT5;CHD3;HHIP;RNF11;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;PHF8;GCH1;GRIN2A;MT2A;QPCT;IMPA1;CRIP2;S100A13;CLIP1;PTGR2;DYRK2
prerank,ephrin receptor binding (GO:0046875),0.5104481368380929,1.3518134816639686,0.10204081632653061,1.0,1.0,6/21,9.31%,PIK3CG;CBL;SRC;FYN;EFNA1;LYN
prerank,rRNA binding (GO:0019843),0.441312707594575,1.3504574006524976,0.10015898251192369,0.9834869402094024,1.0,11/42,11.52%,RPL23;FASTKD2;MRPL18;RPS14;RPL5;EMG1;RPLP0;NGRN;MDM2;RPS9;RPS3
prerank,solute:proton symporter activity (GO:0015295),-0.5107487108232861,-1.3492234196171913,0.12095032397408208,0.4495819299435553,1.0,10/16,36.94%,SLC2A13;SLC25A3;CTNS;SLC39A8;SLC15A4;SLC11A2;SLC2A10;SLC36A1;SLC17A5;SLC2A9
prerank,sterol transfer activity (GO:0120015),-0.5017816204747081,-1.3488295711452702,0.13043478260869565,0.4443450644889494,1.0,7/17,18.72%,GRAMD1B;GRAMD1C;OSBP;ABCA1;STARD5;GRAMD1A;MTTP
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.4072782815881582,-1.3488166227903036,0.09090909090909091,0.43845168571025533,1.0,17/35,18.88%,MPPED2;PLCXD3;PLCE1;ENPP1;PDIA3;NAPEPLD;TDP2;ENPP6;SMPD3;PLCB3;PDE11A;PLCL1;GPLD1;PLD3;APEX2;ENPP3;GDPD3
prerank,anion:anion antiporter activity (GO:0015301),-0.49740418464168795,-1.3482710032593388,0.10697674418604651,0.4340690914760452,1.0,8/17,31.46%,SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC19A1;SLC4A3;SLC25A11;SLC25A5
prerank,semaphorin receptor activity (GO:0017154),-0.5574189241559764,-1.3468307262230228,0.12421052631578948,0.4318378757650869,1.0,6/11,15.77%,PLXNA2;NRP1;NRP2;PLXND1;PLXNB2;PLXNC1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.571071250983312,1.343036517139465,0.1275797373358349,0.9974412118800832,1.0,4/12,12.25%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,chloride channel activity (GO:0005254),-0.3674679175052592,-1.339004989939285,0.0694006309148265,0.4454400280680433,1.0,22/59,27.18%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;SLC26A7;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;GABRA5;GABRG3;GABRA4;GABRG1;TTYH3;GABRA1;TTYH1;FXYD1;SLC1A4
prerank,magnesium ion binding (GO:0000287),0.35858309629028895,1.334072679041475,0.05,1.0,1.0,26/135,13.66%,PCK1;THG1L;MAP2K7;GCLC;SNRK;RAP2A;OXSR1;NUDT5;NME1;NUDT12;TDG;SIK3;UBA2;DXO;EXD2;NIM1K;PAPOLA;SRPK2;NLK;PGP;GNAI1;ADPRH;MAPK12;RRAGC;GSS;NEK6
prerank,serotonin receptor activity (GO:0099589),0.5023494467863284,1.3323645080522424,0.11394557823129252,0.9541176965583013,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5023494467863284,1.3323645080522424,0.11394557823129252,0.9541176965583013,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5023494467863284,1.3323645080522424,0.11394557823129252,0.9541176965583013,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,galactosyltransferase activity (GO:0008378),-0.5527449406978048,-1.3305456395303592,0.11909650924024641,0.46074306600884596,1.0,8/11,33.67%,A4GALT;B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;B4GALT5
prerank,retinoid X receptor binding (GO:0046965),0.5695136204508786,1.3292551115970797,0.1746987951807229,0.9488339558628122,1.0,3/11,10.52%,ARID5A;NR4A2;TACC1
prerank,water transmembrane transporter activity (GO:0005372),-0.5618761427797847,-1.3284952337638,0.12076271186440678,0.4601061503738186,1.0,3/11,24.93%,PDPN;AQP4;AQP11
prerank,metal ion:proton antiporter activity (GO:0051139),0.5530808569970617,1.3256799375812922,0.1412639405204461,0.945812936204773,1.0,4/13,12.25%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,peptidase inhibitor activity (GO:0030414),-0.424056767026213,-1.3235589877754992,0.09307875894988067,0.46661111198187416,1.0,8/33,18.38%,TIMP2;TFPI;GPC3;PSMF1;ITIH2;RENBP;CAST;SERPIND1
prerank,AMP binding (GO:0016208),-0.546684713216091,-1.3230571155841964,0.12804878048780488,0.4622771796909675,1.0,4/11,6.30%,PRKAG2;MPPED2;PRKAG1;ACSS2
prerank,death receptor activity (GO:0005035),0.5887570183116848,1.3214477642377433,0.13307984790874525,0.9458436415995811,1.0,6/11,20.74%,TNFRSF10B;TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;FAS
prerank,insulin-like growth factor binding (GO:0005520),-0.5087602567223324,-1.319988490483606,0.1476510067114094,0.4638030751869093,1.0,6/15,16.09%,IGFBP5;IGFBP2;IGFBP6;IGF2R;IGFBP4;ITGB4
prerank,kinesin binding (GO:0019894),0.46328798843250596,1.315752990548694,0.125,0.953611467999556,1.0,8/27,14.63%,CLSTN1;ACTB;KIFAP3;KIF1B;AP1G1;NEK6;AP1AR;ARHGEF10
prerank,lipase activator activity (GO:0060229),0.5830249304485435,1.310860761115581,0.17013232514177692,0.9557995747187421,1.0,2/10,4.94%,SRC;FYN
prerank,GABA-A receptor activity (GO:0004890),-0.47713732516954477,-1.3092890622970463,0.12731481481481483,0.48526640872176213,1.0,8/18,24.45%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,GABA receptor binding (GO:0050811),-0.5432009229314907,-1.3080555792179365,0.14888888888888888,0.4827943873275082,1.0,3/11,6.93%,ARFGEF2;PLCL2;TRAK1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.4073755953645451,1.306573576871277,0.10664605873261206,0.957015398995353,1.0,18/49,18.06%,ZRANB3;ABRAXAS1;RAD18;TNFAIP3;TAB2;UBL7;TAB3;SPRTN;RAD23A;UBQLN1;TNIP2;BRCC3;MINDY2;UBQLN4;UFD1;UBQLN2;RAD23B;AGAP3
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3313300650948471,1.3029108431428016,0.03225806451612903,0.9558799192168522,1.0,49/248,13.12%,RAC2;DYNC1I1;RALB;DNM3;ABCB10;EEF1A1;RAP2A;PIN1;RUVBL2;GNAQ;RERG;RAB5C;NRAS;GBP3;ATL1;RAB7A;RAB43;RAB11B;RALA;VWA8;GBP4;GNB1;RAB6B;HBS1L;IFT22;RAB6A;RAB14;RUVBL1;GNA12;DNAJC27;GNA11;KIF15;RAB1A;KIF2A;RHOQ;DDX3X;EFTUD2;RHOG;DRG2;GNAI1;RAB5B;RAB22A;RAP2C;EFL1;TBC1D24;CHD3;RIT1;RRAGC;MYO1E
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4636054939720958,-1.3000471011287318,0.1415525114155251,0.4986502179925007,1.0,5/18,8.66%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.3315972250065026,-1.295515947872776,0.05757575757575758,0.5055016433100985,1.0,31/91,22.42%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;MAPT;FRMPD4;WIPI1;SNX21;GSDME;KCNJ2;CLVS2;ACTN2;HIP1R;SYT7;COMMD1;MYO1B;EXOC1;PLCD1;TWF2;SNX3;SNX18;GSDMD;FZD7;VILL;SH3PXD2B;PFN2;RPH3A;AMER1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5524972340125369,-1.2950519830243037,0.15352697095435686,0.50103457341079,1.0,8/10,38.80%,PML;FAN1;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,phospholipase activator activity (GO:0016004),0.5757124779797884,1.2936178488477241,0.20265151515151514,0.982685843314353,1.0,2/10,4.94%,SRC;FYN
prerank,adenylyltransferase activity (GO:0070566),0.48167069331258616,1.291614774634175,0.1487758945386064,0.973662572234863,1.0,10/21,21.53%,GPHN;FLAD1;TENT4A;PAPOLA;NMNAT1;SELENOO;PAPOLG;COASY;TENT2;MTPAP
prerank,calcium-release channel activity (GO:0015278),-0.47136157678729607,-1.2904156155101916,0.15711252653927812,0.5076920882329167,1.0,5/17,22.76%,ITPR1;RYR3;TPCN1;ITPR2;MCOLN1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.43161448552332105,-1.2902870602100158,0.13317757009345793,0.5022852306390182,1.0,12/25,30.08%,MICAL2;CYP27A1;MICAL3;MSMO1;CYP26B1;FMO2;FMO5;MTRR;MICAL1;SQLE;POR;NOS1
prerank,symporter activity (GO:0015293),0.5696678740950195,1.2885321969007275,0.16535433070866143,0.9703238513646181,1.0,1/10,0.82%,SLC4A4
prerank,ubiquitin-specific protease binding (GO:1990381),0.49563764921597064,1.2838278508621062,0.1731123388581952,0.9746920023413564,1.0,5/19,10.24%,DERL2;SPATA2;RAD23A;PARK7;RHBDD2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.34586862193907497,-1.2834570677942856,0.08882521489971347,0.514328033371622,1.0,26/72,22.42%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;FRMPD4;SNX21;GSDME;KCNJ2;ACTN2;HIP1R;SYT7;COMMD1;MYO1B;EXOC1;PLCD1;TWF2;SNX18;GSDMD;FZD7;VILL;PFN2;RPH3A;AMER1
prerank,chloride channel inhibitor activity (GO:0019869),-0.5559723020445659,-1.2827666246633573,0.16233766233766234,0.5103028574582789,1.0,6/10,23.91%,WNK1;STX8;WNK4;WNK3;STX1A;VAMP8
prerank,semaphorin receptor binding (GO:0030215),0.47325419941676433,1.2819236297947154,0.15439856373429084,0.9656980168859218,1.0,6/23,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5395467613692431,-1.2812978623761024,0.17842323651452283,0.5084415200287589,1.0,7/10,33.67%,B4GALT1;B4GALT6;B3GALT5;B3GALT1;B4GALT7;B3GALT2;B4GALT5
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5266647258504915,-1.2781509425213964,0.18340611353711792,0.5109169735550734,1.0,8/12,19.93%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;BMPR1B;BMPR1A;BMPR2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.31074376607749876,1.2744494962269655,0.030201342281879196,0.984009112328865,1.0,92/431,15.89%,PCK1;THG1L;RAC2;ARF5;SNRK;PPIP5K2;RALB;EEF1A1;RAP2A;HSPA8;OXSR1;HSPA4L;ARL5C;ARL4D;NEK11;PNKP;RPS6KA4;RERG;PYGL;RPS6KA5;NRAS;TUBB;NME1;GBP3;ATL1;RRAD;RAB7A;MLKL;RAB11B;RALA;TDG;PEX1;MTHFS;YARS2;GBP4;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;RAB6A;SYN3;RAB14;PEAK1;MINK1;RANBP17;ACVRL1;LATS2;ARL5B;ARF1;RHOQ;NIM1K;MFHAS1;PAPOLA;SRPK2;NLK;P2RX7;RHOG;DRG2;OLA1;PNPLA8;GNAI1;RAB22A;LANCL2;PRKCI;RAP2C;MYO9B;MAP4K4;ABCF2;RIT1;RRAGC;NDUFA13;GSS;PPP5C;TLK2;NEK6;PTPA;GCH1;TWF1;ABCF3;RRM1;DYRK2;ARF6;CDKL5;TOP1;MYH9;MRAS;TUBA1B
prerank,N-acyltransferase activity (GO:0016410),0.44086813383370876,1.2719855772100315,0.18811881188118812,0.9775458174385011,1.0,7/32,12.78%,CERS1;CERS4;PLAAT3;EP300;SIRT1;ESCO1;NAA80
prerank,cGMP binding (GO:0030553),-0.5255287174627996,-1.2687453741953947,0.19467213114754098,0.5304220771989219,1.0,4/11,26.26%,PDE5A;PDE11A;RAPGEF2;PDE2A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4269491070908419,-1.268561597047507,0.16046511627906976,0.5253481038698453,1.0,8/23,19.67%,PLCE1;EDNRA;PLCD3;CHRM3;PLCB3;PLCH1;PLCD1;BDKRB2
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.35120940425462044,-1.267990617885845,0.10326086956521739,0.5214892246299988,1.0,10/55,9.99%,SLC24A3;ITPR1;MCU;CACNA1D;PKD1;ANXA2;TRPC5;SEC61A1;TRPC1;SLC24A2
prerank,FAD binding (GO:0071949),-0.4267585356867887,-1.2674632715503982,0.13711583924349882,0.5174462590791712,1.0,13/24,27.35%,MICAL2;DDO;MICAL3;CRY2;MTHFR;CRY1;SQOR;PRODH;QSOX1;KDM1B;MTRR;MICAL1;SQLE
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3589657845533055,-1.2668288928844218,0.1125,0.5138515925227732,1.0,16/48,24.84%,TRPM3;NALCN;UNC80;SLC41A1;TRPM6;PIEZO2;SLC12A2;TRPC1;ABCC9;SLC12A6;SLC12A4;TRPC6;MCOLN1;DMAC2L;SLC12A7;CALHM5
prerank,syntaxin-1 binding (GO:0017075),-0.4359898680669869,-1.266227023933356,0.15130023640661938,0.5102936944561998,1.0,13/22,35.93%,SNAP25;STXBP5;UNC13C;STXBP1;SNPH;UNC13B;VAMP2;DAPK1;CPLX1;SYP;SYNPR;UNC13A;CPLX2
prerank,regulatory RNA binding (GO:0061980),-0.3748727647904996,-1.2644982287012279,0.1341772151898734,0.5092870141859721,1.0,11/38,14.65%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;DICER1;ZNF346
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5430339228231765,1.2618759477916919,0.20944558521560575,1.0,1.0,4/11,18.78%,NAA25;NAA80;NAA15;NAA50
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4583701858549616,-1.2614505049812506,0.1686182669789227,0.5115255892172076,1.0,9/18,19.93%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;ACVR1B;BMPR1B;BMPR1A;BMPR2
prerank,ATPase binding (GO:0051117),-0.3336657496638369,-1.2603968740235276,0.11209439528023599,0.5091965262741263,1.0,19/71,12.07%,ANK2;SLC2A13;EGFR;SNTA1;TMTC4;TOR1AIP2;ATP1B1;ATP6V1E1;ATP1B3;PTPN3;TRPC1;TOR1AIP1;EZR;ZNHIT6;ATP1B2;CLPP;TCIRG1;ATP6V0A4;ABCA1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.490654816025726,-1.2603884185655503,0.19246861924686193,0.5043229217530952,1.0,5/14,3.54%,SPOCK3;TIMP3;SPOCK1;TIMP2;COL4A3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5600756915877477,1.2598174898020253,0.20676691729323307,1.0,1.0,7/10,19.29%,TNFAIP3;YOD1;DESI2;OTUD5;OTUD4;ATXN3;STAMBP
prerank,miRNA binding (GO:0035198),-0.39694427749302963,-1.2595109520134253,0.10679611650485436,0.5019395575976194,1.0,10/30,14.65%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;ZNF346
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5154289751463459,1.259498368611768,0.19480519480519481,0.9858739729172976,1.0,2/14,0.92%,ALDH1L1;AASS
prerank,endopeptidase activity (GO:0004175),-0.2725972823650502,-1.2594645680111907,0.010582010582010581,0.49724846094267766,1.0,78/257,22.88%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;USP40;USP29;PCSK2;PCSK5;MMP16;ADAMTS6;ADAMTSL5;MALT1;ADAMTS17;MMP14;USP13;BACE2;ADAMTS9;F3;RHBDL3;ADAM19;ADAMTS5;PDIA3;USP11;RHBDD1;HTRA3;DPP4;NLN;TPP2;ADAMTS1;PSMA2;ADAMTSL4;BACE1;PSMA6;FAP;LGMN;CLPP;PREP;PSMA1;ADAMTS3;CTSO;USP38;PIK3IP1;USP34;AFG3L2;PCSK6;USP20;PSMA5;DDI2;ADAMTS10;USP7;MBTPS2;CASP7;USP10;USP1;USP16;CTSZ;USP42;PSMB3;ACE;PITRM1;USP5;ADAMTS15;ADAMTS16;SPG7;MMP2;ADAM33;CASP2;ADAMTS20;RHBDF1;USP35;USP49;KLK2;USP2;USP46;CASP9;CASP3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5459338428499076,1.2586991424346394,0.1934826883910387,0.9732315187512272,1.0,4/11,11.13%,PRMT3;FBXO11;PRMT9;CARM1
prerank,Wnt-activated receptor activity (GO:0042813),-0.4780416015479404,-1.2583638267619395,0.1827309236947791,0.495150839196702,1.0,6/15,10.31%,PKD1;FZD6;RYK;ROR1;LRP5;FZD2
prerank,GTPase activity (GO:0003924),0.32573683739578896,1.2541337263345524,0.08354114713216958,0.9777446865353603,1.0,39/192,12.99%,RAC2;RALB;DNM3;EEF1A1;RAP2A;GNAQ;RERG;RAB5C;NRAS;GBP3;ATL1;RAB7A;RAB43;RAB11B;RALA;GBP4;GNB1;RAB6B;HBS1L;IFT22;RAB6A;RAB14;GNA12;DNAJC27;GNA11;RAB1A;RHOQ;DDX3X;EFTUD2;RHOG;DRG2;GNAI1;RAB5B;RAB22A;RAP2C;EFL1;TBC1D24;RIT1;RRAGC
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5501055146185354,1.2539575283653108,0.21169354838709678,0.9629409911136728,1.0,4/11,15.71%,RDH13;RDH11;RDH14;AKR1A1
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.44451056211251605,-1.2530205015090157,0.16778523489932887,0.503391012680052,1.0,4/19,6.32%,GRM5;EFNA5;ABI1;ERCC6
prerank,MAP kinase kinase activity (GO:0004708),0.508098798642816,1.2516369603684787,0.20985401459854014,0.9577120713459807,1.0,4/15,6.54%,MAP2K7;MAP2K5;MAP3K9;PAK3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5167574462474032,-1.246214553345928,0.20652173913043478,0.5150569237001117,1.0,8/12,24.45%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,chemorepellent activity (GO:0045499),0.44519033228453625,1.2449195563214484,0.17525773195876287,0.9739997376914392,1.0,6/25,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,cation transmembrane transporter activity (GO:0008324),0.4013601942826965,1.2433565203859247,0.16123778501628663,0.9661995725656634,1.0,12/48,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC39A1;SLC3A2;SLC6A6;SLC25A2;SFXN1;SLC38A5;SLC66A1;SLC25A38;SLC7A5
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.32528680696301426,-1.2400874729147193,0.12349397590361445,0.5254676258992805,1.0,42/78,29.73%,CFLAR;USP40;USP29;CAPN2;MALT1;USP13;PDIA3;USP11;LGMN;CASP12;CTSO;USP38;USP34;USP20;USP7;CASP7;USP10;USP1;USP16;CTSZ;USP42;USP5;CAPN15;CASP2;USP35;USP49;CAPN1;USP2;USP46;CASP9;CASP3;USP24;CTSK;CAPN10;SFRP1;CAPN5;CTSF;CTSB;CTSC;UCHL1;GPAA1;CTSS
prerank,mRNA 3'-UTR binding (GO:0003730),-0.31980116472012676,-1.2352703508772402,0.0924092409240924,0.5325790877631758,1.0,26/79,20.36%,CELF2;DDX5;RBMS1;CPEB4;CPEB1;CPEB2;ELAVL2;PUM1;ELAVL4;YBX3;PUM2;HNRNPA2B1;SECISBP2;ELAVL3;TP53;RBM4;RPS7;DAZAP1;CSDC2;PABPC4;RBMS3;RNPS1;CIRBP;HNRNPA0;RNF40;IGF2BP2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.36819385593010184,1.2349979152422716,0.1580547112462006,0.9901688815307998,1.0,17/69,16.51%,CERS1;ZDHHC17;CERS4;ZDHHC13;PLAAT3;SOAT1;EP300;LPCAT3;ZDHHC14;ESCO1;ZDHHC15;CREBBP;ZDHHC9;ZDHHC7;NAA15;MBOAT7;ELP3
prerank,poly-pyrimidine tract binding (GO:0008187),-0.40973628564297676,-1.2337223709488938,0.18055555555555555,0.5313468552888782,1.0,7/23,16.15%,RBMS1;HNRNPH1;KHDRBS1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5037487746468059,1.2321540621455394,0.20938628158844766,0.9886332132778087,1.0,6/13,17.84%,PRKAR1A;GSK3A;PJA2;PKIA;RYR2;PRKAR2A
prerank,motor activity (GO:0003774),0.3754537348120577,1.2308360447377897,0.16289592760180996,0.9802104387798708,1.0,15/60,15.74%,DYNC1I1;KIF18A;PIN1;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;MYO1E;KIF3B;KIF6;APPBP2;DYNC1I2;MYH9
prerank,cholesterol transfer activity (GO:0120020),-0.4682870001778478,-1.2300598799048255,0.2149122807017544,0.5359905724561423,1.0,6/16,18.72%,GRAMD1B;GRAMD1C;ABCA1;STARD5;GRAMD1A;MTTP
prerank,nuclear receptor binding (GO:0016922),0.34223312067407674,1.2299156112554712,0.13191489361702127,0.9701929616381677,1.0,29/111,14.55%,DCAF1;ARID5A;NR4A2;GAS2L1;LEF1;DDX54;RERG;SRARP;CCDC62;PHB2;KDM3A;EP300;MED12;ACTN4;SIRT1;GTF2H1;PKN1;PARK7;RNF6;BUD31;WBP2;ESR1;TACC1;MED4;JMJD1C;YWHAH;NCOA7;CNOT1;BAZ2A
prerank,phospholipase binding (GO:0043274),0.5295459044792323,1.229130769825432,0.2261029411764706,0.9600463170738549,1.0,3/13,6.70%,SRC;FYN;SYK
prerank,exonuclease activity (GO:0004527),0.39538802618768526,1.2271929503326369,0.19682539682539682,0.9545538200733954,1.0,12/46,13.16%,AEN;REXO2;RAD1;APLF;DCLRE1B;CNOT7;EXOSC9;XRN2;DXO;EXD2;CNOT6;EXOSC1
prerank,filamin binding (GO:0031005),-0.510738751286835,-1.2247597643983645,0.21560574948665298,0.5449074795890841,1.0,8/11,38.49%,DPYSL3;SYNPO2;CEACAM1;FBLIM1;CRMP1;MICALL2;RFLNA;RFLNB
prerank,pre-mRNA binding (GO:0036002),-0.3930545206690647,-1.2245195441083114,0.19689119170984457,0.5406476660104143,1.0,9/28,16.92%,CELF2;DDX5;CELF4;SRSF6;RNPC3;HNRNPA1;RBM4;SLU7;RBM7
prerank,anion channel activity (GO:0005253),-0.33199088379486774,-1.2229621080445885,0.13293051359516617,0.5397214479937348,1.0,12/61,7.73%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;LRRC8D;SLC26A7;LRRC8B;VDAC1;GLRA3;GABRG2;GLRA1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.46560776498225115,-1.2219534004665948,0.2323943661971831,0.5379204328844617,1.0,5/15,23.50%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.4070289390222407,-1.2217374969318908,0.18028846153846154,0.5338082873681115,1.0,8/25,18.34%,ADAP2;PLEKHA2;GAB2;HIP1R;FCHSD2;DAPP1;COMMD1;ARAP3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5279755659150223,-1.2199276360790403,0.23809523809523808,0.5334941932761255,1.0,7/10,24.45%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.39826458757243194,-1.2192258241186398,0.1614457831325301,0.5304436450839328,1.0,12/27,23.50%,ITPR1;SLC41A1;MRS2;SLC12A2;KCNA1;SLC9B2;MAGT1;ITPR2;SLC11A2;CNNM2;ATP2B3;SLC4A8
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3372974000685249,-1.2184191872495052,0.13370473537604458,0.5280240950652216,1.0,16/55,19.20%,SLC16A12;SLC6A13;SLC13A3;SLC7A2;PDPN;SLC16A7;SLC7A14;SLC6A12;SLC22A4;SLC25A32;SLC38A11;SLC16A11;SLC19A1;SLC16A2;SLC38A7;SLC16A9
prerank,epidermal growth factor receptor binding (GO:0005154),-0.40234352930642003,-1.217839428068421,0.17274939172749393,0.525125974437422,1.0,8/25,12.24%,ERBB4;SNX2;SNX4;FER;EFEMP1;CNOT9;PLSCR1;GRB2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.4479046647890576,-1.217427164128422,0.20484581497797358,0.5216848042369547,1.0,9/17,30.02%,DPYD;TECR;BLVRA;BLVRB;LBR;SRD5A3;DECR2;PECR;DHCR24
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4791876129417387,-1.216394108723357,0.2076271186440678,0.5199137464222171,1.0,9/13,30.95%,PLPPR1;PLPP3;PLPPR5;LPIN1;PLPPR4;LPIN2;PLPP5;LPIN3;PLPPR2
prerank,tRNA methyltransferase activity (GO:0008175),0.48285834798413174,1.2153955973109738,0.22784810126582278,0.9924372981979624,1.0,4/16,11.85%,BCDIN3D;THUMPD2;METTL2B;METTL2A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.46261688173305515,-1.213432070158144,0.21700223713646533,0.5229854704471717,1.0,1/15,1.27%,PLA2G4A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3979633567583755,-1.2121668855648038,0.1943127962085308,0.5217525699328492,1.0,12/26,23.56%,SLC16A12;SLC6A13;SLC6A1;SLC16A7;SLC6A12;SLC27A1;SLC16A11;SLC16A2;SLC5A6;SLC16A9;SLC16A4;SLC6A11
prerank,U6 snRNA binding (GO:0017070),0.5013138216732828,1.2119343644421325,0.2527075812274368,0.9940263496230387,1.0,2/14,1.26%,EIF5A;RBM22
prerank,insulin-like growth factor I binding (GO:0031994),-0.4915264744479092,-1.2094602928691807,0.252212389380531,0.5246969075966647,1.0,5/13,16.09%,IGFBP5;IGFBP2;IGFBP6;IGFBP4;ITGB4
prerank,protein tyrosine phosphatase activity (GO:0004725),0.35401385850775285,1.2030883731349116,0.1748148148148148,1.0,1.0,15/71,11.62%,PTPRR;PTPN18;PTPRG;PTPRJ;PTPRC;PTPRM;PTPRB;PTPRE;PTP4A2;PTPN12;PTPRT;EYA3;DUSP11;PGP;HACD2
prerank,alpha-actinin binding (GO:0051393),-0.4001784481280337,-1.200494405909536,0.19953051643192488,0.5426696510438708,1.0,8/24,13.62%,CACNA1C;PDLIM5;CACNA1D;PDLIM7;PALLD;SYNPO2;RARA;PDLIM1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3612131596521885,-1.198166372726106,0.16752577319587628,0.5442262879163154,1.0,12/37,18.43%,SLCO3A1;SLC22A8;SLC16A7;CYB5A;UQCRH;SLC22A4;COX8A;UQCRC1;NDUFA4;SLC22A6;COX7A2L;COX6A1
prerank,WW domain binding (GO:0050699),0.4263142474728888,1.1946978687226142,0.2170940170940171,1.0,1.0,2/26,4.98%,PRRG4;TCEAL9
prerank,aspartic-type peptidase activity (GO:0070001),-0.5203582378528511,-1.1938535522096656,0.258130081300813,0.5502171294638497,1.0,4/10,13.99%,BACE2;BACE1;CTSD;DDI2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.42622720055914465,1.1908471614982192,0.2333931777378815,1.0,1.0,4/27,6.96%,SLC9A7;SLC3A2;SLC9A6;SLC9A8
prerank,adenyl nucleotide binding (GO:0030554),0.5187231697032997,1.1894209527525508,0.25594149908592323,1.0,1.0,3/11,6.60%,PFN1;BAG1;GRPEL2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5187231697032997,1.1894209527525508,0.25594149908592323,1.0,1.0,3/11,6.60%,PFN1;BAG1;GRPEL2
prerank,carboxypeptidase activity (GO:0004180),-0.36028017394218753,-1.1868678871378437,0.21323529411764705,0.5628554722454636,1.0,9/35,16.78%,AEBP1;AGBL4;PEPD;AGBL3;SCPEP1;CPM;CTSA;NAALAD2;CTSZ
prerank,transcription coregulator binding (GO:0001221),0.3704444558665714,1.1858171995176254,0.20408163265306123,1.0,1.0,16/50,13.66%,EZH2;RPL23;EED;HDAC3;UBE2I;CNOT2;PPARD;RELA;LMO2;ESR1;TERT;THRB;CTBP1;HDGF;CTBP2;NEK6
prerank,Tat protein binding (GO:0030957),0.5302092708328264,1.1833668420554886,0.2888015717092338,1.0,1.0,6/10,19.09%,ACTB;MDFIC;GABARAPL1;SMARCA4;NPM1;SMARCB1
prerank,muscle alpha-actinin binding (GO:0051371),-0.4560799882771803,-1.1832592111652105,0.25,0.5678782108003437,1.0,7/15,21.97%,PDLIM5;PDLIM7;PALLD;SYNPO2;PDLIM1;PDLIM2;PDLIM4
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.335667464988998,-1.182821399359316,0.18384401114206128,0.5646824424582404,1.0,15/49,14.55%,ANXA3;PLA2G4A;CPNE8;PCLO;ANXA2;ANXA4;SYT9;ESYT1;ANXA1;ANXA5;SYT12;SYT11;SYT4;CPNE2;SYT7
prerank,neuropeptide binding (GO:0042923),-0.42570157753665616,-1.1815432794342244,0.25869565217391305,0.5634653646705111,1.0,4/18,22.54%,SORL1;GPR37;OPRM1;GPR149
prerank,phosphatidylinositol kinase activity (GO:0052742),0.48751827547897636,1.1753877834348785,0.26159554730983303,1.0,1.0,6/15,14.60%,PIK3CG;PIK3C2G;PIKFYVE;PI4KA;PIK3CD;PIK3C2A
prerank,frizzled binding (GO:0005109),-0.3584702158578703,-1.1745791919366944,0.22654462242562928,0.5764550189913429,1.0,13/34,28.39%,WNT5B;RYK;RNF43;WNT4;DVL3;ZNRF3;WNT9A;LRP6;DVL1;FZD7;SFRP1;FZD1;MYOC
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3990512304497425,1.17422078778739,0.2176759410801964,1.0,1.0,12/33,16.46%,REXO2;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN2;CNOT6;CNOT6L;NOCT;ERI2;PARN
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.4131789839317071,1.1718155818684428,0.25127334465195245,1.0,1.0,6/28,10.33%,MAP2K7;RPS6KA1;MAP2K5;MAP3K9;PAK3;PRKAA2
prerank,I-SMAD binding (GO:0070411),-0.4498021415871466,-1.1699567542581188,0.24074074074074073,0.5837352609262072,1.0,6/13,14.23%,SMAD3;TGFBR1;CTNNB1;SMAD4;SMAD6;SMAD5
prerank,transcription corepressor binding (GO:0001222),0.41475192923646187,1.1660274891043252,0.23986486486486486,1.0,1.0,10/27,15.79%,EZH2;EED;HDAC3;CNOT2;ESR1;CTBP1;HDGF;CTBP2;NEK6;WIZ
prerank,actin binding (GO:0003779),-0.2661555296123404,-1.1633109006783044,0.09486166007905138,0.5959429279247276,1.0,29/170,8.83%,SORBS1;CALD1;MAP1B;PAWR;KCNMA1;PDLIM5;GSN;SYNE2;PARVA;MICAL2;PLEKHH2;LIMA1;PACRG;MOBP;MAPT;TPM1;MACF1;MTSS1;PDLIM7;MICAL3;FMN2;VCL;ARPC1A;COBL;TLN2;P4HB;PHACTR3;EZR;SMTN
prerank,store-operated calcium channel activity (GO:0015279),-0.4990877036794873,-1.1629029015145904,0.2708757637474542,0.5927020020811995,1.0,3/10,8.60%,STIM2;TRPC5;TRPC1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.35200599494380846,-1.1593894973790242,0.22015915119363394,0.5976782348983276,1.0,14/33,27.32%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;GTF2B;ZNF326;SUPT4H1;LLPH
prerank,CXCR chemokine receptor binding (GO:0045236),0.507857180681983,1.1586853739061425,0.2886178861788618,1.0,1.0,1/11,2.58%,CXCL12
prerank,RNA binding (GO:0003723),0.27070186040309857,1.1579851077948435,0.03834510595358224,1.0,1.0,368/1321,19.41%,THG1L;LRRFIP1;SORBS2;MAZ;CMSS1;SNRPD2;ZC3H12D;RPS19BP1;NCBP1;RPL30;EIF5A;ILF3;THUMPD1;UTP20;RSRC2;SYNE1;KHDRBS3;RBM22;FAU;RALYL;TRIM28;RSL24D1;EEF1A1;RPP25L;UTP18;HSPA8;POLR2B;MRPL23;RPL17;RPL23;PATL2;EIF2S1;EIF2A;FASTKD2;RPL31;PRPF31;PRPF3;RPL3;SNRPD1;RPS21;HNRNPH2;DDX54;MANF;DDX10;LARP4B;PCBP1;NAP1L4;FLNB;MEX3B;FARS2;UBA1;PPIB;IFIT1;NUDT5;NME1;PHF5A;ZFP36L1;HNRNPAB;SLC3A2;GOT2;SF1;QKI;PRPF40A;PFN1;EIF3B;RBBP6;SMG1;HNRNPK;YY1;PPIG;METAP2;RPL35A;SEC23IP;PSMC1;SAMSN1;FAM50A;MYO5A;UBE2I;CPSF4;MYEF2;RPS14;FXR1;NFX1;RTCA;RPL8;CHTOP;YARS2;RPL5;SRSF10;ABCF1;SSBP1;RO60;POLR1G;MRPS12;RPS12;CDK11B;RBM20;SLC4A1AP;SFPQ;LONP1;RPS26;ACTN4;RPL37A;HNRNPC;TXN;ZNF638;GEMIN5;MAP4;CS;SMNDC1;FAM120C;PUS10;ADAR;YTHDC1;IMMT;PYM1;ELP1;ZFR;TRMT10B;FYTTD1;RPL4;RARS2;SRSF4;RBM34;EMG1;TRIM25;MRPL20;SECISBP2L;EIF4H;SNU13;XPO5;POP5;RPLP0;NOVA2;SARNP;DHX32;EXOSC9;NGRN;SF3A1;XRN2;ARF1;PCID2;BCLAF1;DXO;FBRSL1;PATL1;PARK7;SUCLG1;AKAP8L;SYF2;TARDBP;ZMAT3;TSFM;RPS28;U2AF1;CPSF6;TAF15;RPS24;RRP7A;DUSP11;S100A16;ASCC3;FAM133B;GLRX3;EIF4G2;CCAR2;RBM45;BCCIP;NCBP3;TERT;SRPK2;RPS9;RPS23;RPL24;DDX3X;ADARB2;RPL34;NGDN;CISD2;EFTUD2;FAM32A;ERH;TDRD3;NANOS3;MATR3;APTX;DRG2;AGO4;HELZ;EIF4B;RPS11;RPS3;PA2G4;ANKHD1;ZBED4;PTBP1;DDX27;HDGF;PCBP3;MRPS15;ACO1;NUFIP2;ILF2;MRPS24;CRKL;FKBP4;G3BP2;ARCN1;ZC3H14;RBM10;API5;SRFBP1;STRAP;NDUFV3;CHD3;HELB;HSPE1;TUT7;RRP8;RNMT;EXOSC1;PPHLN1;UTP11;DDX55;HEATR6;CSRP1;ANKRD17;RPS15A;RBM26;RPL23A;PTCD1;RPL21;SRP9;RPL35;YBX1;SRSF7;PURG;HEATR1;CNOT1;TASOR;CAPRIN1;BAZ2A;SCAF8;DCP1A;ATP5F1C;UCHL5;SNRPA;FUS;TFAM;SSB;PTCD2;PCDHGA9;TUT4;MRPS28;MRPS35;LARP1B;EIF5;TCF20;RBM4B;SF3B6;MOV10;PPP1R8;HNRNPL;NOCT;NKAP;TCERG1;TRA2B;TOP1;ADARB1;ANG;MYH9;SLBP;TUBA1B;TCP1;PRKRIP1;TDRD7;UPF3B;EIF1AX;DKC1;U2AF2;RSL1D1;PURB;ZCCHC17;OTUD4;NSUN6;NAA15;ENDOV;HARS2;PARN;ACAA2;WDR33;N4BP1;LARP4;PRKDC;KPNB1;SPATS2;LSM1;CALR;RPL19;STAU2;SERPINH1;NONO;URB1;NPM1;RPL38;EIF2S2;SNRPA1;HNRNPF;CKAP4;UBAP2;RANGAP1;EIF3A;RPL36;RCC1L;YTHDC2;DCAF13;SMG6;STAT3;RPSA;ZC3H13;DHX8;DDX23;TSNAX;RPL26;LUC7L2;RPS8;SMG5;HEXIM1;SAFB;MYO18A;RPL15;RPL10;NUP42;HDAC2;RDX;CCDC47;PDIA4;USP36;DDX60;RPL32;ZYX;SNRPD3;MRPS9;RC3H1;RPS2;ZNF106;NSUN2;NSRP1;EIF4G1;CLUH;TRIM56;PRRC2C;PRRC2B;MRPL13;TFRC;DHX36;TOP3B;TFB1M;YWHAE;RPL27A;HNRNPM;TRNT1;EIF3E;NOP58;LARP1;NVL;DCP1B;MTIF2
prerank,cyclic nucleotide binding (GO:0030551),-0.40125997839533756,-1.1576451310907725,0.2635294117647059,0.5975153658585736,1.0,6/21,16.21%,HCN1;PDE5A;PDE11A;PDE4B;SLC19A1;RAPGEF2
prerank,PDZ domain binding (GO:0030165),-0.3120915299487937,-1.1575417135977382,0.1907356948228883,0.5934935655980847,1.0,14/61,10.31%,TGFBR3;GRID2;PLEKHA2;SDC2;CXADR;ARHGAP29;DLG4;SRR;CRIM1;CIT;MAP2K2;NLGN1;SLC22A4;FZD2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4044948195126016,1.1571439131288197,0.23688663282571912,1.0,1.0,5/29,5.65%,PRKAR1A;RPTOR;SPRED1;CIB1;CDKN1A
prerank,death receptor binding (GO:0005123),-0.4517626361951996,-1.1541707853836043,0.3012295081967213,0.5974768486784724,1.0,5/15,17.90%,EDA;CASP8AP2;MADD;NGF;TMBIM1
prerank,ubiquitin protein ligase binding (GO:0031625),0.2905071665390008,1.152203101378978,0.156289707750953,1.0,1.0,62/253,17.18%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;TRIM28;ARIH1;SLF1;MAP1LC3B;HSPA8;RPL23;CCT2;SPOP;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;RPL5;BAG1;TRAF5;SMAD7;AXIN1;MAGEC2;NDUFS2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;CUL3;MID1;CHEK2;NEK6;PSMD1;FAF1;APC;NFKBIA;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;DNM1L;ABI2;SLF2;BECN1;CALR;ATXN3
prerank,clathrin adaptor activity (GO:0035615),-0.4453974257415381,-1.1495837286653452,0.2748414376321353,0.6051870967232795,1.0,7/15,13.04%,DAB2;AP2B1;AP2A2;STON2;AP2A1;STON1;HIP1R
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.34797218915004857,-1.1482017026270084,0.2179176755447942,0.6046269846867603,1.0,2/38,0.17%,MAGI2;SORBS1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.36157948056871303,-1.1476185361979347,0.2562814070351759,0.6020559292930767,1.0,17/31,28.65%,HCN1;SLC12A2;KCNK5;KCNA1;KCNK10;ABCC9;SLC12A6;TMEM38A;SLC12A4;KCNQ4;SLC12A9;KCNA2;SLC12A7;KCNK9;SLC12A8;SLC12A5;KCNK1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.48259068053276094,1.147085099434229,0.311284046692607,1.0,1.0,6/13,17.17%,PIK3CG;PIK3C2G;PIKFYVE;PIK3CD;PIK3C2A;PIP4K2A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4062796660182031,1.1470536968771514,0.2743055555555556,1.0,1.0,3/26,3.56%,CSGALNACT1;CHSY3;EXTL2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4670865534517384,1.1394198755462501,0.30740037950664134,1.0,1.0,7/14,17.18%,YOD1;DESI2;USP15;OTUD5;MINDY2;USP9X;ATXN3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3883300670862071,-1.1386734747981972,0.2847380410022779,0.6199133521546986,1.0,5/21,32.47%,GRM5;CHRFAM7A;CHRNA7;GRIA1;CHRNB1
prerank,tubulin binding (GO:0015631),0.2834257561286519,1.137539097478261,0.18984280532043532,1.0,1.0,57/295,14.18%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;TTLL1;GAS2L1;MAP1LC3B;ALMS1;CETN3;TTLL12;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;CCT5;FYN;DST;KRIT1;DIP2B;CRIPT;FGF13;ARHGEF7;CCDC88C;DNAL1;UXT;CLIP2;AGTPBP1;MAP4;DAG1;TRPV4;RAB11FIP5;TBCEL;REEP3;KIF15;STARD9;PRUNE1;KIF2A;PAK1;KIF13A;DDX3X;RMDN3;RPS3;PRNP;MAP4K4;AGBL5;MID1;KIF3B;KIF6;RABGAP1;TTLL7;APC;SPEF1;EFHC2
prerank,amyloid-beta binding (GO:0001540),-0.2921924880125045,-1.1357563650253986,0.20238095238095238,0.6230637098964286,1.0,19/79,13.50%,LRP1;GRIA4;GRIA2;GRIN2B;COL25A1;FZD6;PGRMC1;SORL1;CACNA1B;TM2D1;HSPG2;LDLR;NLGN1;BACE1;EPHB2;VBP1;APBA1;GSAP;PFDN2
prerank,microtubule motor activity (GO:0003777),0.3567392694880135,1.1349811044801277,0.25862068965517243,1.0,1.0,12/51,14.76%,DYNC1I1;KIF18A;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;KIF3B;KIF6;APPBP2;DYNC1I2
prerank,beta-tubulin binding (GO:0048487),-0.35803530394259386,-1.1339169166948144,0.26573426573426573,0.6237744621472933,1.0,11/31,13.07%,EML4;GJB6;SMC3;PACRG;LRPPRC;PEX14;HTT;IFT74;ARL8A;TAOK1;PDCD5
prerank,microtubule binding (GO:0008017),0.2900997348328026,1.1317037451632748,0.21890547263681592,1.0,1.0,39/222,13.23%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;GAS2L1;MAP1LC3B;ALMS1;CETN3;HAUS4;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;DST;KRIT1;CRIPT;FGF13;CCDC88C;UXT;CLIP2;CAMSAP2;MAP4;TRPV4;REEP3;KIF15;STARD9;KIF2A;KIF13A;RMDN3;RPS3;PRNP;MAP4K4;MID1;KIF3B;KIF6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3281330556971001,1.12645927186144,0.2564841498559078,1.0,1.0,15/75,15.80%,IMPDH1;ABCC4;SPR;ME3;HMGCR;KDSR;KCNAB1;HSD17B11;NSDHL;RDH11;HSD17B4;RDH10;BDH2;AKR1A1;HPGD
prerank,3'-5' DNA helicase activity (GO:0043138),0.4394842435485042,1.1256933924599515,0.3352380952380952,1.0,1.0,6/16,21.38%,ERCC3;ASCC3;FBH1;NAV2;MCM2;DHX9
prerank,DNA binding (GO:0003677),0.26449431573917204,1.1195454514970566,0.1511627906976744,1.0,1.0,131/694,16.21%,TBX4;LRRFIP1;IRX1;ERCC3;IMPDH1;CTCFL;RAD18;MECOM;CHCHD2;SIM1;ARID5A;ILF3;TFCP2;NR4A2;BANF1;ATF6;TRIM28;CTC1;LEF1;PNKP;KLF2;GTF3C1;PCBP1;PAX8;ZBTB33;ZMYM4;NR5A1;MAP1S;RLF;SIRT3;MMP12;ERCC4;RAD1;FLI1;SMARCA2;SOX2;MEIS1;YY1;USF2;EP300;RFX3;TBX1;TDG;CARF;GTF3C5;SSBP1;CEBPG;CALCOCO1;FOXF2;PPARD;POLE;SFPQ;PMS2;CDC45;LONP1;ZNF638;DRAP1;DCLRE1B;CLOCK;ZNF3;HEY2;ZBTB14;MLH1;PMS1;SOX13;RELA;SPRTN;CENPC;POLA1;HOXA7;PCID2;BCLAF1;RAD23A;TFAP4;MSH3;ERG;PARK7;TARDBP;ZKSCAN3;AIFM1;RYBP;ING2;HIC2;TERT;THRB;DDX3X;RBPJ;RAD51B;HP1BP3;CREBBP;APTX;APP;RPS3;TOP3A;POLR3F;HDGF;TIGD2;ILF2;E2F3;SP1;TAF4B;NBN;IRF2;CHD3;RNF11;NUP35;MPG;EPAS1;DDIT3;HES1;YBX1;GRHL1;BRIP1;TSHZ1;TFAM;INO80;EZH1;TAF6L;TOP1;FOXJ3;TAF1;ANG;ELK4;BCL6;GTF3C2;SMARCA4;TCF7L1;TCF3;TSHZ2;ZBTB18;PURB
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2815608309452609,1.1186634355667842,0.21696969696969698,1.0,1.0,36/254,12.68%,SOX30;ATF3;CTCFL;MECOM;ONECUT1;TFCP2;NR4A2;ATF6;LEF1;ELK3;GABPA;SMAD1;PRDM15;RLF;PRDM4;MYBL2;MEIS1;YY1;VEZF1;CEBPG;FOXF2;CLOCK;RELA;HOXA7;MDM2;TFAP4;ERG;KLF6;ESR1;RBPJ;NFIC;E2F3;SP1;MZF1;SMARCD1;IRF2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3867065869197924,-1.1170782958963554,0.28794642857142855,0.6618950240518205,1.0,3/21,4.02%,PDE1A;PDE5A;PDE1C
prerank,tau protein binding (GO:0048156),0.36931272706643686,1.1164175457743837,0.29449838187702265,1.0,1.0,8/40,6.91%,GSK3A;PIN1;ACTB;PPP2CA;APOE;FYN;EP300;PPP2CB
prerank,SUMO transferase activity (GO:0019789),0.44722852419966846,1.1156159374281103,0.31684981684981683,1.0,1.0,5/16,11.40%,TRIM28;UBE2I;MDM2;PIAS2;PIAS1
prerank,ATP binding (GO:0005524),0.28147824942962224,1.1155578034903053,0.2255729794933655,1.0,1.0,56/266,15.74%,THG1L;SNRK;PPIP5K2;HSPA8;OXSR1;HSPA4L;NEK11;PNKP;RPS6KA4;PYGL;RPS6KA5;NME1;MLKL;TDG;PEX1;MTHFS;YARS2;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;SYN3;PEAK1;MINK1;ACVRL1;LATS2;NIM1K;PAPOLA;SRPK2;NLK;P2RX7;OLA1;PNPLA8;LANCL2;PRKCI;MYO9B;MAP4K4;ABCF2;NDUFA13;GSS;PPP5C;TLK2;NEK6;PTPA;TWF1;ABCF3;RRM1;DYRK2;CDKL5;TOP1;MYH9
prerank,DNA polymerase activity (GO:0034061),0.41179749493790574,1.1152932794054435,0.3087971274685817,1.0,1.0,5/22,10.59%,POLK;POLE;POLD3;POLA1;TERT
prerank,calcium-activated potassium channel activity (GO:0015269),0.4742111617470024,1.1146483834310714,0.33079847908745247,1.0,1.0,4/11,9.46%,KCNN2;KCNU1;KCNMB2;KCNMB3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3545261575888116,1.113822804480355,0.277602523659306,1.0,1.0,11/44,14.56%,MECOM;EZH2;EED;TTLL12;SMYD3;SETD5;SETD3;SETD1B;KMT5B;DOT1L;NSD2
prerank,GTPase inhibitor activity (GO:0005095),-0.4477255328282909,-1.112849226318723,0.33059548254620125,0.66936239243899,1.0,7/13,29.15%,CPEB2;IQGAP1;IQGAP2;CDC42SE1;ARL2;RHOH;RTKN
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2855308707185777,-1.1125408179074823,0.25559105431309903,0.6656971578950319,1.0,12/82,11.69%,SPOCK3;TIMP3;SPOCK1;TIMP2;TFPI;ANXA2;COL4A3;ROCK1;BIN1;PSMF1;ITIH2;RENBP
prerank,vitamin D receptor binding (GO:0042809),-0.43009209740098636,-1.1110851410446925,0.29723991507430997,0.665130465287213,1.0,11/14,32.38%,MED13;MED1;MED17;SNW1;RXRA;THRAP3;TAF11;MED24;MED16;MED30;TAF7
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4360844352126085,-1.1107978313036446,0.344578313253012,0.6614795821935301,1.0,5/14,26.06%,SLC26A7;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,alkali metal ion binding (GO:0031420),-0.44107634921524397,-1.109584606695075,0.33186813186813185,0.6603318109454377,1.0,3/13,7.60%,ATP1A2;HDAC4;ATP1A1
prerank,3'-5' exonuclease activity (GO:0008408),0.3572604619779862,1.108034034157453,0.3210862619808307,1.0,1.0,14/45,16.46%,REXO2;RAD1;APLF;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN2;CNOT6;CNOT6L;NOCT;ERI2;PARN
prerank,GTPase binding (GO:0051020),0.28618612264863674,1.1033793152361433,0.2503259452411995,1.0,1.0,58/194,17.01%,LCP1;SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;CYRIB;MYO5A;CIB1;GNB1;IARS1;LAMTOR1;USP6NL;AP1G1;TRIP11;RABGAP1L;FGD5;RAPGEF6;XPO5;RASIP1;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;RRAGC;USP33;KIF3B;RABGAP1;AP3M1;YBX1;ANKRD27;BICD2;ATG16L1;RCC1;RUSC2;PPP6R1;TMEM127;ATG14;RAB3GAP1;WHAMM;CDKL5;BRAF;DOCK4;EXOC2;DNM1L;ABI2;BNIP3;CYFIP1;BECN1
prerank,adenyl ribonucleotide binding (GO:0032559),0.27655865915781375,1.1032114242088757,0.23826714801444043,1.0,1.0,60/291,15.74%,THG1L;GCLC;SNRK;PPIP5K2;PDE4D;HSPA8;OXSR1;HSPA4L;NEK11;PNKP;RPS6KA4;HMGCR;PYGL;RPS6KA5;NME1;MLKL;TDG;PEX1;MTHFS;YARS2;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;SYN3;PEAK1;MINK1;ACVRL1;LATS2;NIM1K;PAPOLA;SRPK2;NLK;P2RX7;OLA1;PNPLA8;LANCL2;PRKCI;MYO9B;MAP4K4;ABCF2;NDUFA13;GSS;PPP5C;TLK2;NEK6;MIEF1;PTPA;TWF1;ABCF3;RRM1;DYRK2;CDKL5;TOP1;MYH9
prerank,glutamate receptor activity (GO:0008066),-0.3906307410833536,-1.103150156703288,0.31840796019900497,0.6725689505321739,1.0,4/19,1.54%,GRIA4;GRIA2;GRID2;GRM5
prerank,protein serine/threonine kinase activity (GO:0004674),0.2722914573971492,1.1027872495173368,0.231651376146789,1.0,1.0,75/334,16.75%,STK32A;MAP3K11;MAPK3;SNRK;GSK3A;OXSR1;MAP3K7;CDK19;PLK2;NEK11;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;STK35;MAP3K9;PKN3;SMG1;SLK;MAP3K4;MAPK8;PAK3;CSNK1G3;SIK3;SYK;CDK11B;SBK1;PIM1;TRIO;PIKFYVE;MOK;MINK1;CDK4;ACVRL1;LATS2;CDKL4;NRBP1;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;PRKCI;MAST4;MAP4K4;MAPK6;IKBKB;MAPK12;CHUK;CHEK2;TLK2;NEK6;BRD2;CSNK2A2;MAP3K10;BMP2K;DYRK2;CDKL5;TOP1;CAMK2G;TAF1;ATR;BRAF;PTK2B;PIK3R4;CDK14;WNK2;RPS6KC1;PRKDC
prerank,hydro-lyase activity (GO:0016836),0.34937471024353467,1.101355405252848,0.32038834951456313,1.0,1.0,11/41,16.09%,ENO4;CA2;CA4;CDYL;PARK7;HACD2;HSD17B4;ACO1;ECHDC1;NAXD;ECHS1
prerank,carboxy-lyase activity (GO:0016831),0.40245231672363,1.1008988829531916,0.35261194029850745,1.0,1.0,7/23,16.01%,MLYCD;DDC;AMD1;UXS1;ODC1;ECHDC1;CSAD
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.47698586158353007,-1.0998872838879639,0.35375494071146246,0.676611018877206,1.0,4/10,16.98%,DSE;GLCE;RENBP;DSEL
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.37281291758513,1.0974539984981702,0.32894736842105265,1.0,1.0,12/33,16.97%,ARIH1;DCUN1D4;UBA2;AUP1;UBE3D;PARK7;RPS3;RNF180;TCERG1;RNF125;DCUN1D2;DCUN1D1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.30452081836432304,-1.0963700404894303,0.27887323943661974,0.6812802287207327,1.0,15/53,16.06%,DPYD;MICAL2;AOX1;DDO;MICAL3;CRY2;XDH;DLD;MTHFR;CRY1;NOX4;KDM1A;SQOR;PRODH;QSOX1
prerank,metalloexopeptidase activity (GO:0008235),-0.31010176717314986,-1.096190452437716,0.2692307692307692,0.6774870498240276,1.0,10/51,8.27%,CPQ;AEBP1;MMP16;AGBL4;MMP14;PEPD;RNPEP;TRHDE;ANPEP;AGBL3
prerank,retinoic acid receptor binding (GO:0042974),0.42357058316104546,1.0921495454200378,0.3502824858757062,1.0,1.0,5/17,14.50%,ARID5A;NR4A2;ACTN4;TACC1;CNOT1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.35719122212274546,1.0918091540870922,0.3360655737704918,1.0,1.0,14/42,19.53%,PIN1;BCAR3;PFN1;SAMSN1;YWHAB;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1;YWHAE;FBXW7
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.44349506146440276,1.0910277021261539,0.35660377358490564,1.0,1.0,5/14,14.37%,MAL;BCL2L13;BAD;NOD1;APAF1
prerank,calcium channel inhibitor activity (GO:0019855),0.4794872235989706,1.090744564893872,0.3425925925925926,1.0,1.0,1/11,0.30%,PHPT1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.27305029575393,1.0907328506755984,0.26184538653366585,1.0,1.0,62/268,17.18%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;TRIM28;ARIH1;SLF1;MAP1LC3B;HSPA8;RPL23;CCT2;SPOP;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;RPL5;BAG1;TRAF5;SMAD7;AXIN1;MAGEC2;NDUFS2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;CUL3;MID1;CHEK2;NEK6;PSMD1;FAF1;APC;NFKBIA;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;DNM1L;ABI2;SLF2;BECN1;CALR;ATXN3
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3570759221322713,-1.0887502103644175,0.3049645390070922,0.6929092907693822,1.0,5/26,11.91%,AEBP1;AGBL4;PEPD;AGBL3;CPM
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3617170585468039,-1.0880409516008533,0.3215962441314554,0.6904738855974044,1.0,11/25,21.51%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;PARP1;SIRT5;PARP16;PARP2
prerank,chemokine binding (GO:0019956),-0.347822200802264,-1.0874275084028686,0.33251231527093594,0.6878214782941641,1.0,24/30,63.13%,PDPN;CCR9;ACKR3;ITGA4;CX3CR1;ITGB3;HMGB1;ZFP36;ITGAV;CCR5;ACKR1;CCR2;CXCR4;PLP2;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;FGF2;ITGB1;CCR6;CXCR2
prerank,GTPase regulator activity (GO:0030695),-0.24247987811432603,-1.0862111045359808,0.22321428571428573,0.6868062848196388,1.0,57/212,16.63%,RIMS1;RANBP3L;ARHGAP42;ALDH1A1;ADGRB3;CPEB2;IQGAP1;DOCK1;TBCK;ERRFI1;ARHGAP10;NRP1;HACD3;ARHGEF10L;DEPDC5;SGSM2;WASL;ARHGAP29;RGS7;GARNL3;ARHGAP32;ARHGAP28;RAB3GAP2;ARFGAP1;BCR;ARHGAP20;ELMOD1;TBC1D22B;NPRL3;TBC1D8B;RGS12;STARD13;ELMOD2;SMAP2;STXBP5;SEC23A;GPSM1;RANBP3;RP2;GMIP;ARHGAP22;GDI1;MTSS2;SIPA1;SIRPA;TBC1D13;TBC1D10A;GNB5;RALBP1;ELMOD3;TBC1D9B;RALGDS;IQGAP2;ARHGAP26;RAPGEF2;RGS20;JUN
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.43915630968816244,-1.0854414080664645,0.3613963039014374,0.6846901836163692,1.0,9/12,52.13%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,ribosomal large subunit binding (GO:0043023),-0.4569145492998762,-1.0851900983630878,0.3699788583509514,0.6811292142756383,1.0,4/11,13.86%,CPEB2;LTN1;RBM3;MRRF
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3807660479121925,-1.0845109876023231,0.33910891089108913,0.6786828932575865,1.0,12/19,24.45%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1
prerank,actinin binding (GO:0042805),-0.37440480744040594,-1.080796516178849,0.3303769401330377,0.6838693750881648,1.0,7/21,12.04%,CACNA1C;PDLIM5;CACNA1D;SYNPO2;NFKB1;RARA;CSRP2
prerank,Toll-like receptor binding (GO:0035325),0.47264498100589014,1.0806129288142514,0.3762993762993763,1.0,1.0,1/11,2.92%,TIRAP
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.3746037428748684,-1.0804030719453226,0.36302895322939865,0.680889089362536,1.0,1/20,0.02%,DLG2
prerank,histone methyltransferase activity (GO:0042054),0.3612745570201697,1.0778991592352216,0.3420138888888889,1.0,1.0,8/32,14.58%,EZH2;EED;TTLL12;SMYD3;CARM1;KMT5B;DOT1L;NTMT1
prerank,endodeoxyribonuclease activity (GO:0004520),0.41058075929205895,1.0777946013712123,0.36713286713286714,1.0,1.0,6/20,17.42%,ZRANB3;ERCC4;APLF;RPS3;ENDOV;DCLRE1C
prerank,syntaxin binding (GO:0019905),-0.2881850049226286,-1.0767190870104644,0.323943661971831,0.6862376485366328,1.0,22/61,18.87%,SNAP25;STX16;STX8;SYT9;GOLGA2;STXBP5;TMED9;STXBP4;ABCA1;SYT12;RAB11A;UNC13C;STXBP1;SNPH;UNC13B;VAMP2;VPS54;PTPN2;SYT2;DAPK1;VAMP1;SNAP29
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.3401677889827762,-1.0760276647835394,0.3511450381679389,0.6839991285774026,1.0,13/28,26.56%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1;CHRNA7
prerank,hormone receptor binding (GO:0051427),-0.42156391509954594,-1.075339721980262,0.41139240506329117,0.6817800569233194,1.0,3/14,10.52%,JAK1;NCOA6;SOCS2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.4434134598108586,-1.0751630589196874,0.3852295409181637,0.6782654784325275,1.0,8/11,36.52%,UBR5;UBE4A;UBE2K;STUB1;UBOX5;UBE4B;PRPF19;RBX1
prerank,protein kinase C activity (GO:0004697),0.44005272351810687,1.074920926423478,0.36952714535901926,1.0,1.0,4/14,12.23%,PRKCH;SMG1;PKN1;PRKCI
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.30465423678403236,-1.073979635972662,0.35185185185185186,0.6773308302742211,1.0,8/47,5.61%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC6A1;SLC7A14;SLC1A5
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.4636526740702195,-1.073767630437712,0.36084452975047987,0.6738690652374393,1.0,6/10,22.88%,CFLAR;CASP12;CASP7;CASP2;CASP9;CASP3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3222361333815239,-1.073473660413705,0.34540389972144847,0.6708575533082662,1.0,3/38,2.62%,SPOCK1;TFPI;ANXA2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.44087424683298626,-1.0721461393556426,0.3645621181262729,0.6703893758942426,1.0,4/12,20.03%,IGF1;SOCS2;IGF2;PIK3R1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.36317521667038266,-1.0694476353763491,0.3595238095238095,0.6737849292758307,1.0,14/23,39.72%,WIPI1;CLVS2;HIP1R;COMMD1;SNX3;SH3PXD2B;HIP1;GBF1;JPH2;MAPKAP1;PLA2G4E;PHLDA3;WDR45;ATP13A2
prerank,amino acid binding (GO:0016597),-0.3284677767791292,-1.0690449582532082,0.35584415584415585,0.670963847067909,1.0,7/31,10.84%,GRIN2B;GLRB;SRR;GLRA3;CASTOR2;GLRA1;DDAH1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.38981784929498997,1.0687468067324932,0.37608318890814557,1.0,1.0,5/22,9.11%,ZRANB3;TNFAIP3;TAB2;TAB3;SPRTN
prerank,MAP kinase phosphatase activity (GO:0033549),0.4558734734778959,1.0665693662366493,0.3969171483622351,1.0,1.0,1/12,1.27%,DUSP7
prerank,endonuclease activity (GO:0004519),0.3459886419028856,1.0663653221374914,0.34418604651162793,1.0,1.0,5/49,5.73%,ZRANB3;ZC3H12D;PNKP;ERCC4;APLF
prerank,nuclease activity (GO:0004518),0.33453897580320724,1.064099048576601,0.34810126582278483,1.0,1.0,7/52,9.40%,AEN;PNKP;NME1;MAP1S;RNASE6;XRN2;RNASE12
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.43090674891529024,-1.061723275421524,0.3814229249011858,0.68548693101038,1.0,7/12,18.95%,SULF1;SULF2;ARSB;ARSG;ARSK;ARSI;GNS
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27833367923532226,1.0608845496080945,0.3425559947299078,1.0,1.0,22/173,10.44%,SOX30;LRRFIP1;ATF3;IRX1;DACH1;KLF8;GTF2IRD1;ELK3;ZBTB33;BCL6B;HEY1;YY1;NFX1;PPARD;ZNF3;HEY2;ZBTB14;SOX13;RELA;TRPS1;ZKSCAN3;HIC2
prerank,G protein-coupled receptor activity (GO:0004930),0.26953779152690593,1.0589366849155968,0.3383084577114428,1.0,1.0,13/239,6.34%,MTNR1A;GPR176;GPR52;ADGRE1;GPR63;NPFFR1;ADGRL4;ADGRL3;PAX8;TSHR;HCRTR1;XPR1;RXFP1
prerank,fibroblast growth factor binding (GO:0017134),-0.3685489735469276,-1.058633659372295,0.37844036697247707,0.6894934397536193,1.0,4/21,10.73%,FGFR2;CEP57;THBS1;KL
prerank,transforming growth factor beta binding (GO:0050431),-0.3559799206812122,-1.0564922893207604,0.38663484486873506,0.6908535916364948,1.0,11/23,24.95%,TGFBR3;TGFBR1;TGFBR2;ACVR1;THBS1;LTBP1;CD109;TWSG1;NRROS;TGFB3;VASN
prerank,double-stranded RNA binding (GO:0003725),0.3155306174298237,1.0559747036228349,0.3555219364599092,1.0,1.0,26/70,21.38%,LRRFIP1;ILF3;SLC3A2;FXR1;ADAR;ZFR;EIF4H;DDX3X;ADARB2;APTX;AGO4;EIF4B;ILF2;ADARB1;TUBA1B;PRKRIP1;STAU2;DDX60;RC3H1;TFRC;DHX36;DHX30;AGO1;HSP90AB1;DGCR8;DHX9
prerank,ribosomal small subunit binding (GO:0043024),0.41219179928026933,1.0553716895414225,0.379746835443038,1.0,1.0,9/17,20.22%,NME1;PIM1;EIF4H;DDX3X;EIF4B;NPM1;LARP1;MTIF2;EIF1
prerank,cardiolipin binding (GO:1901612),0.46605546106442464,1.0546850201266782,0.41284403669724773,1.0,1.0,2/10,5.21%,MME;UQCC3
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.27680959088560525,-1.0541501196659187,0.34173669467787116,0.6929232044978252,1.0,14/70,17.34%,MGAT4C;GXYLT2;OGT;B4GALT1;CHSY1;HEXA;CSGALNACT2;HEXB;XXYLT1;LARGE1;B3GALT5;B3GALNT1;B3GALT1;POGLUT3
prerank,kinase binding (GO:0019900),-0.21754521445052366,-1.0529471013348661,0.23684210526315788,0.6922552972489493,1.0,115/434,19.24%,DLG2;ANK2;PRKAG2;BICD1;MAPK4;NBEAL1;SASH1;EGFR;GSN;SMAD3;IQGAP1;WWC2;PDGFRB;PKD1;DNAJC3;SNAP91;ERRFI1;TNS2;UFL1;CYLD;TOM1L2;DLG4;MAPT;IFNAR2;CTNNB1;WNK1;RHOA;AP2A2;MAML1;FLNA;PRKAG1;UNC5C;GHR;VDAC1;PIP5K1A;SLC12A2;CIT;PRKCD;CAB39;SKI;HTT;IRAK1;IL31RA;SRCIN1;TAX1BP1;CDKN1B;IRAK3;AP2A1;GOLGA2;CEP152;SYN1;SIK1;RND3;CNOT9;DLG3;PRKACA;RHOBTB2;CCND3;GSK3B;STRADA;CAMK2N1;EEF2;VRK2;DCX;TP53;ILK;PER1;PRKAB2;HSF1;RHOB;GRB2;RPS7;TPRKB;RPS6;RHOBTB1;GYS1;TOLLIP;PIK3IP1;DLG1;MSH2;RELB;SHC3;DNM1;POLR2A;CSPG4;PTK2;MAP3K12;CAV2;PTPN22;CCNK;TOM1L1;DCTN1;TRAF2;PTPN23;TCF7L2;PTPN2;CEP250;STX1A;GPRC5B;IRAK4;SLC12A4;NR3C1;SV2A;DVL1;MAP3K1;CDC42;MAVS;JTB;ADD2;PARP1;MSN;TRIM5;ATF5;HNRNPA0;STUB1
prerank,mRNA 5'-UTR binding (GO:0048027),0.3777921975844696,1.0522205443613877,0.3883333333333333,1.0,1.0,8/24,19.34%,CCT5;RPS14;RPL5;DDX3X;RSL1D1;RPL26;DHX36;LARP1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4346709234612902,1.0520809584102562,0.38740458015267176,1.0,1.0,4/13,14.07%,THUMPD2;TRMT11;TRMT10B;WDR4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.44200785123164354,-1.0519607432045177,0.4046610169491525,0.6908205354713337,1.0,3/11,28.51%,DDAH1;DDAH2;PADI2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.45602839632298114,1.0518669727505392,0.4153543307086614,1.0,1.0,2/11,3.76%,NUDT11;NUDT5
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25774711691396734,1.051358136327198,0.3286549707602339,1.0,1.0,74/346,16.65%,FBXL6;RNF7;CBL;TRIM28;ARIH1;RNF149;TNFAIP3;RNF38;RFFL;BIRC2;RSPRY1;NEDD4L;NEURL2;VPS11;ANKRD39;NHLRC1;RBBP6;FBXL5;UBE3A;TRIM14;FBXW2;IRF2BPL;RNF130;NFX1;COP1;TRAF5;RNF187;PPP1R11;LMO7;TTC3;TRIM25;AKTIP;FBXO11;TRAF3;RBCK1;MDM2;PJA2;RFWD3;MYCBP2;UBE3D;RNF6;ZNRF1;FBXO7;UBE2M;RNF13;RNF25;CHFR;ANAPC11;DTX4;ANAPC4;RNF11;CUL3;UBE2R2;RNF146;RNF216;TSPAN17;RNF180;TRIM27;RNF20;FANCL;TRIM3;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF128;RNF125;UBE2H;KLHL13;VPS18
prerank,snRNA binding (GO:0017069),0.34038488007519324,1.050904685771902,0.3780687397708674,1.0,1.0,14/42,18.65%,EIF5A;RBM22;PRPF31;GEMIN5;SF3B3;SNU13;COIL;EFTUD2;SNRPA;RBM41;SNRPA1;HEXIM1;SNRPB2;SNRPD3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.43897753150256547,-1.0508299075703074,0.38943248532289626,0.6898022502713942,1.0,6/11,22.88%,CFLAR;CASP12;CASP7;CASP2;CASP9;CASP3
prerank,cation:chloride symporter activity (GO:0015377),0.464887180177843,1.0501481772465757,0.4095238095238095,1.0,1.0,1/10,0.15%,SLC12A1
prerank,Hsp90 protein binding (GO:0051879),-0.32192436650962997,-1.048642927175059,0.3857493857493858,0.6916049608643768,1.0,10/33,19.24%,PACRG;MAPT;SLC12A2;PPID;HSF1;USP19;NPAS2;NR3C1;TSC2;STUB1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.4168674308821567,-1.0480351828664505,0.3991031390134529,0.689460348229955,1.0,5/13,23.65%,FAN1;DICER1;DNASE1L1;ZGRF1;SLX4
prerank,protein phosphatase binding (GO:0019903),-0.25053223937964675,-1.0464524462315934,0.3289902280130293,0.6897366787287377,1.0,39/117,21.97%,EGFR;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;MAPT;CTNNB1;PXN;VCP;MYO16;ENSA;STAT6;CDKN1B;ARPP19;MAP3K5;TP53;IKBKE;KIF3A;SIRPA;VRK3;RACK1;PTK2;MTMR9;PPME1;MTMR4;TRAF2;FBXL2;SNX3;SHOC2;MET;PPP1R16A;PIK3R1;PPP6R3;ITGA1;PPP1R3B;ADCY8;SH3RF2;PDLIM4
prerank,voltage-gated sodium channel activity (GO:0005248),-0.3627219094085784,-1.0463495597758015,0.3967889908256881,0.6863668014274437,1.0,5/22,13.06%,HCN1;SCN8A;SCN3A;SCN1A;CACNA1G
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.34897808428203564,-1.0437921124077614,0.39775280898876403,0.688917698707514,1.0,6/23,16.11%,PDE1A;PDE5A;PDE1C;PDE11A;PDE4B;ADPRM
prerank,protein kinase activator activity (GO:0030295),-0.2790045964968278,-1.0429324942629277,0.37317784256559766,0.6874609290895457,1.0,15/60,14.80%,PRKAG2;GRM5;IQGAP1;ABI1;WNK1;ERCC6;CAB39;MAP2K2;STRADA;STK11;TAOK1;FAM20A;IGF2;MADD;RPLP1
prerank,peptide hormone receptor binding (GO:0051428),0.4515042253344977,1.0425026336802712,0.42376237623762375,1.0,1.0,1/11,3.53%,GNRH1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3852245961264398,1.0405137112103167,0.4194690265486726,1.0,1.0,2/22,3.68%,DUSP7;DUSP12
prerank,microtubule minus-end binding (GO:0051011),0.43963585341721056,1.0399327006178403,0.4003690036900369,1.0,1.0,3/13,7.37%,HAUS4;TUBGCP5;CAMSAP2
prerank,ion gated channel activity (GO:0022839),-0.34821774591017196,-1.0383386026305523,0.38694638694638694,0.6952634381561581,1.0,10/24,28.95%,ANO3;ANO1;TMEM63A;ANO6;TMEM63B;ANO10;KCNT1;TTYH3;TTYH1;TMEM63C
prerank,ubiquitin binding (GO:0043130),-0.27060848981513624,-1.038254100793567,0.38439306358381503,0.691861804673908,1.0,30/73,20.91%,SMAD3;UBXN7;UBE2N;SIRT2;UBXN2A;USP13;ILRUN;UBXN2B;USPL1;RNF168;NPLOC4;NSFL1C;BUB3;TOLLIP;IKBKG;DDI2;RNFT1;RNF19B;TSG101;TOM1L1;UCHL3;GGA3;USP16;RNF31;OTULINL;USP5;RAE1;NEDD4;DNAJB2;HSPB1
prerank,myosin binding (GO:0017022),-0.28364806271655396,-1.0374824091772403,0.3547486033519553,0.6901394337136203,1.0,9/55,7.31%,CALD1;KIRREL1;GSN;RAB3C;MOBP;RHOA;SPATA6;TRAK1;RAB27B
prerank,protein homodimerization activity (GO:0042803),0.24631160143320585,1.0319078714637393,0.37323177366702937,1.0,1.0,110/589,16.21%,CIDEA;MIGA1;LRRFIP1;ATF3;CADM1;MAP3K11;SYNE1;BANF1;ABCB10;TMEM266;GLB1;GYG1;PECAM1;ABCG2;BCL2L2;GREM1;ZHX3;TRIM8;NUDT5;MAP3K9;GBP3;MME;EXT2;APOE;SLK;PHB2;TOX3;TRIM14;B2M;USF2;TPI1;SMIM1;TBX1;TDG;FXR1;KCNN2;YARS2;GBP4;PRPS1L1;PRPS1;SSBP1;PTPRT;PEX7;CHMP1A;SFPQ;ACTN4;F11R;SPPL3;HARS1;TXN;DCLRE1B;AXIN1;GALM;SNX1;RASIP1;RELA;CARNMT1;CSF1R;RAB11FIP2;RABEP1;NRBP1;FZD9;EXD2;TFAP4;MSH3;PARK7;CACYBP;S100A16;TERT;NQO2;GTF2A2;CISD2;NOD1;HSD17B4;ATG7;BNIP3L;MYO9B;SP1;IKBKB;CRPPA;MZF1;STARD3NL;CHUK;TPM2;DSCAML1;TENM4;PAPSS1;GSS;MID1;PLEK;CHEK2;DDIT3;HES1;GRHL1;TRIM27;PTPA;GCH1;MAP3K10;IMPA1;S100A13;UXS1;ODC1;TPD52L1;CAMK2G;ANG;MYH9;STARD3;KLHL7;TCF3;DNM1L
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.23437241258035257,-1.0302004788052612,0.38839285714285715,0.7051040307838629,1.0,54/181,21.70%,ARNT2;SMAD3;MIER1;PRRX1;HDAC4;CHD4;MAPK14;CTNNB1;RBL2;HDAC1;GTF2I;MED1;TTC8;PPARGC1A;ANXA4;WWP2;PPARA;MTA3;LDB1;SPEN;BHLHE40;SNW1;PSMA6;RXRA;GSK3B;SMARCD3;MTA1;TP53;CRY1;TBX3;DDRGK1;NCOA1;PIAS3;KDM1A;DACT1;ATN1;BBS2;COMMD7;TEAD3;TAF6;CTDP1;TCF7L2;JUN;TADA3;MTDH;BBS5;STAT1;MTA2;PIAS4;BHLHE41;HSPB1;DTX3L;ATF4;ELK1
prerank,disordered domain specific binding (GO:0097718),0.3738837518140563,1.0296865715353183,0.427255985267035,1.0,1.0,4/23,9.39%,BCL2L2;FYN;CALM3;MDM2
prerank,nuclear receptor coactivator activity (GO:0030374),0.3203342661472073,1.0287067190160193,0.38656716417910447,1.0,1.0,16/52,14.35%,CCDC62;DCAF6;CALCOCO1;MED12;ACTN4;ATXN7L3;PKN1;BUD31;CCAR2;TACC1;USP22;CARM1;MED4;SS18;CNOT6;NCOA7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.46360683088369786,1.0282699905694583,0.42828685258964144,1.0,1.0,1/10,1.27%,DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.46360683088369786,1.0282699905694583,0.42828685258964144,1.0,1.0,1/10,1.27%,DUSP7
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3831252073708662,1.0274838578689673,0.41081081081081083,1.0,1.0,4/21,9.29%,POLK;POLE;POLD3;POLA1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.3891668407224755,-1.027248689598938,0.41541755888650966,0.7089934206480969,1.0,10/15,35.99%,KMT2A;RBBP5;KMT2B;KMT2D;SETD4;WDR5;WDR82;PRDM9;CXXC1;SETMAR
prerank,sequence-specific DNA binding (GO:0043565),0.2450460513171061,1.026873157584732,0.40280777537796975,1.0,1.0,65/590,10.81%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;CHCHD2;ARID5A;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;CTC1;LEF1;HES6;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;HEY1;NR5A1;SIRT3;MMP12;IRF9;PRDM4;MYBL2;FLI1;BBX;SOX2;SMG1;YY1;GMEB2;KDM2A;ZNF740;USF2;CPSF4;RFX3;TBX1;CHTOP;CEBPG;CALCOCO1;FOXF2;PPARD;LONP1;CLOCK;TET3;HEY2;ZBTB14;ACD;SOX13;UPF2;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;ESR1;TERT;THRB;RBPJ
prerank,cadherin binding (GO:0045296),0.2526254051771756,1.0241107778746172,0.3940828402366864,1.0,1.0,98/315,19.94%,LRRFIP1;EFHD2;PSMB6;CBL;PTPRJ;NUDC;VASP;BSG;HSPA8;EIF2A;GLOD4;PTPRM;EEF1D;EHD4;PCBP1;SRC;PTPRB;FLNB;MRTFB;CDH2;SLC3A2;PROM1;ESYT2;PFN1;HNRNPK;SLK;RAB11B;EPS15L1;YWHAB;PTPRT;CDH12;RPS26;F11R;RUVBL1;TRIM25;DOCK9;ITGA6;EIF4H;TJP1;SNX1;RAB1A;RANBP1;PARK7;EIF4G2;RPL24;DDX3X;RPL34;PI4KA;OLA1;AHSA1;PICALM;CRKL;UNC45A;CDH5;ERC1;EPS8L1;RPL23A;GIPC1;APC;HCFC1;TWF1;ABCF3;ASAP1;EIF5;FXYD5;GAPVD1;MYH9;RSL1D1;PACSIN2;CDH13;PFKP;CD2AP;LDHA;BAIAP2;CAPZA1;UBAP2;RANGAP1;PTPN11;EPN2;ARGLU1;CD46;GOLGA3;RPL15;RDX;CNN3;RPS2;FNBP1L;SH3GLB1;BZW2;YWHAE;EIF3E;LARP1;ADD1;KIF5B;SEPTIN9;RPL14;PKN2;PAK2
prerank,growth factor receptor binding (GO:0070851),-0.2535249611615344,-1.0240922322996344,0.3778501628664495,0.7127236506113237,1.0,18/95,16.35%,ERBB4;PDGFRB;SNX2;FGF1;SNX4;FER;IL6R;PIBF1;EFEMP1;PDGFRA;ITGA5;CNOT9;PLSCR1;KL;GRB2;IL6ST;ARF4;PDGFD
prerank,GTPase activator activity (GO:0005096),0.253379900665936,1.0233558288109175,0.4211764705882353,1.0,1.0,85/313,17.58%,THG1L;RGS2;TIAM1;VAV3;GNAQ;EEF1D;RGS5;EVI5L;CYTH4;CHN2;NUCB2;TBC1D30;TBC1D8;RALGAPA2;RGS8;ITSN1;TBC1D9;STXBP5L;RASGRP3;ARHGAP25;TBC1D10B;DENND5B;ARHGEF6;LAMTOR1;USP6NL;ARHGEF7;TBC1D4;CCDC88C;RALGAPB;RAPGEF3;DENND1A;RABGAP1L;RGS10;RAP1GDS1;ARHGEF18;RAPGEF5;RGS3;FGD5;EIF2B3;RAPGEF6;DOCK9;TBC1D12;MYCBP2;RANBP1;PLCB1;ACAP2;OPHN1;TBC1D25;ARHGAP39;SBF2;NF1;PREX2;ADPRH;MYO9B;SMAP1;LARS1;TBC1D14;RABGAP1;EEF1B2;EPS8L1;RGL2;ARHGAP15;ELMO1;ANKRD27;RALGAPA1;DENND4C;SYDE1;ARHGEF10;ASAP1;RCC1;DENND1B;DOCK8;RAB3GAP1;GAPVD1;DOCK4;DNM1L;RASGRF2;ARHGAP27;WDR41;ARFGAP2;ASAP2;ARHGAP9;RGL1;RANGAP1;RCC1L
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.45279723648598097,1.0228732667793194,0.43238095238095237,1.0,1.0,2/10,7.85%,MECOM;SETD5
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3750840964882496,1.0225797594766137,0.4163763066202091,1.0,1.0,8/22,18.04%,ATP6V1D;ATP2A2;ATP6V0D1;ATP6V0E1;ATP2C1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.340353363071842,1.0116249772341486,0.4463087248322148,1.0,1.0,10/34,13.09%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.340353363071842,1.0116249772341486,0.4463087248322148,1.0,1.0,10/34,13.09%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,ion channel inhibitor activity (GO:0008200),0.33802331244757294,1.0101697440680388,0.44462540716612375,1.0,1.0,3/35,4.22%,PHPT1;RSC1A1;NEDD4L
prerank,ATPase regulator activity (GO:0060590),-0.2907647217826817,-1.0060380401203666,0.4019607843137255,0.7550889953907283,1.0,11/38,17.91%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;BAG3;DNAJC19;TOR1AIP1;ATP1B2;FNIP1;ATP5IF1;DNAJB4
prerank,organic anion transmembrane transporter activity (GO:0008514),0.27250531435875375,1.0053425481761307,0.4674634794156706,1.0,1.0,29/134,16.57%,SLC7A8;SLC1A1;SLC36A4;ABCC4;SLC25A1;SLC25A24;ABCG2;SLC3A2;SLC52A2;SLC52A3;SLC6A6;SLC17A6;SLC1A2;SLC35A1;SLC35B1;SLC25A2;SFXN5;SFXN1;SLC25A12;SLC35A3;MPC2;SLC38A5;SLC66A1;SLCO1C1;SLC25A21;SLC25A42;SLC16A1;SLC25A38;SLC25A25
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3664658345305165,-1.0045175931738455,0.4469525959367946,0.7550953889294981,1.0,8/17,21.80%,GRIA4;GRIA2;GRIN2B;GRIK4;GRIK1;GRIK3;GRIN2D;GRIN1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.41524011044325865,1.0044171726445075,0.4424778761061947,1.0,1.0,2/13,1.52%,PTPRJ;IL1R1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3387674836180042,-1.0028435163921996,0.44254278728606355,0.7554959165980842,1.0,8/24,21.37%,PLA2G4A;PLEKHA8;OSBP;OSBPL5;SNX3;ARFIP2;GSDMD;OSBPL8
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3772227865126192,-1.0024062069024495,0.46004319654427644,0.7529126816194103,1.0,10/16,53.40%,PIR;CDO1;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,G protein-coupled receptor binding (GO:0001664),0.2682071789423898,1.001708627436065,0.44798890429958393,1.0,1.0,12/132,8.84%,RTP3;REEP1;SAG;HSPA8;GNAQ;CXCL12;INSL3;CCDC88C;GNA12;CCL25;WNT5A;GNA11
prerank,pyridoxal phosphate binding (GO:0030170),-0.3437323922983476,-1.0008486423239809,0.43099273607748184,0.7532268829361445,1.0,3/20,4.23%,PYGB;ABAT;SRR
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23935696020577346,1.000845795265435,0.4699570815450644,1.0,1.0,80/597,14.11%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;ARID5A;ONECUT1;FOXN2;TFCP2;NR4A2;MTERF3;TAL1;ATF6;LEF1;HES6;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;ORC3;HEY1;NR5A1;IRF9;PRDM4;MYBL2;FLI1;BBX;SMARCA2;SOX2;YY1;GMEB2;ZNF740;USF2;CPSF4;BEND3;RFX3;TBX1;CEBPG;CALCOCO1;PPARD;SFPQ;CDC45;CLOCK;ORC4;HEY2;ZBTB14;SOX13;RELA;CENPC;JUND;POLA1;HOXA7;TFAP4;ERG;KLF6;ESR1;THRB;CARM1;ORC2;NFIC;ZBED4;E2F3;SP1;MZF1;IRF2;CHD3;TBP;ZBTB45;TGIF1;HDAC5;DDIT3;THRA;HES1;YBX1;GRHL1;SP8
prerank,myosin V binding (GO:0031489),0.4002995286014668,1.000654677007534,0.46296296296296297,1.0,1.0,4/15,8.22%,RAB11B;RAB6B;RAB6A;RAB14
prerank,thyroid hormone receptor binding (GO:0046966),0.34827122324023596,1.000090475762348,0.44932432432432434,1.0,1.0,7/28,11.72%,ARID5A;GAS2L1;MED12;GTF2H1;TACC1;MED4;JMJD1C
prerank,single-stranded RNA binding (GO:0003727),0.3266368589530375,0.9971498750045763,0.46314102564102566,1.0,1.0,18/43,21.38%,ILF3;FXR1;LONP1;ZFR;EIF4H;DDX3X;ADARB2;AGO4;EIF4B;PTBP1;U2AF2;ENDOV;HNRNPF;DDX60;AGO1;AQR;CNBP;DHX9
prerank,chemoattractant activity (GO:0042056),-0.3270501737276264,-0.9966092866324339,0.45161290322580644,0.7604238333270483,1.0,14/26,44.03%,BMP4;SCG2;CX3CL1;VEGFA;VEGFB;PGF;FGF10;FGF7;HMGB1;HMGB2;HGF;MIF;NTF3;GDNF
prerank,CCR chemokine receptor binding (GO:0048020),-0.3223830980574012,-0.9952847832047858,0.460093896713615,0.760086569979021,1.0,6/28,22.13%,CNIH4;CCL14;NARS1;NES;CX3CL1;CCL13
prerank,omega peptidase activity (GO:0008242),-0.25167567925488743,-0.9951282265580259,0.4298507462686567,0.756716495315858,1.0,35/89,23.52%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;GGT5;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;COPS5;MYSM1;JOSD1;GGH;USP35;USP49;USP2;USP46;USP24
prerank,chemokine receptor activity (GO:0004950),-0.3354198093610245,-0.9946221201446344,0.47216035634743875,0.7543502300025116,1.0,18/24,63.13%,CCR9;ACKR3;CMKLR1;CX3CR1;CCR5;GPR35;CCR2;CXCR4;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,glycerophospholipid flippase activity (GO:0140333),0.4335493864693327,0.9941124328801398,0.4826254826254826,1.0,1.0,4/11,13.91%,ATP8A1;ATP11A;ATP11C;ATP10A
prerank,kinase inhibitor activity (GO:0019210),-0.3085431788812634,-0.9928343331387259,0.4490861618798956,0.7549567427725438,1.0,17/33,32.80%,PARVA;DNAJC3;GMFB;TAOK3;CDKN1B;DUS2;LRP6;SH3BP5;SH3BP5L;RHOH;TRIB1;QARS1;SNCA;CDKN1C;NCK1;MAPK8IP1;SMCR8
prerank,LRR domain binding (GO:0030275),0.401403321931758,0.9928302951955534,0.5,1.0,1.0,5/14,13.40%,POLR2J;MRTFA;ZXDC;ERC1;DDIT3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3501817961161935,-0.9926594736342532,0.44724770642201833,0.7518073520723064,1.0,8/18,28.13%,ALDH1A1;ALDH1A2;ALDH6A1;ALDH3A2;ALDH2;AKR1B10;ALDH9A1;ALDH18A1
prerank,potassium ion antiporter activity (GO:0022821),0.3991997496267869,0.9916659968382876,0.46654275092936803,1.0,1.0,3/15,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,voltage-gated ion channel activity (GO:0005244),-0.38680376951094697,-0.9901564162940879,0.4470842332613391,0.754407288648719,1.0,3/14,5.72%,HCN1;KCND2;VDAC1
prerank,ribosome binding (GO:0043022),-0.2820866122124768,-0.9886730196356467,0.48247978436657685,0.7545454545454546,1.0,12/46,14.35%,CPEB4;CPEB1;CPEB2;SEC61A1;EIF3C;YTHDF1;EEF2;TMCO1;SRP72;SRP19;RACK1;NOMO1
prerank,mRNA binding (GO:0003729),0.2507594006189053,0.9882939361620094,0.4862604540023895,1.0,1.0,76/249,19.40%,ZC3H12D;NCBP1;KHDRBS3;EIF2A;LARP4B;PCBP1;ZFP36L1;HNRNPAB;SF1;QKI;CCT5;HNRNPK;MYEF2;RPS14;FXR1;RPL5;RBM20;SLC4A1AP;RPS26;HNRNPC;GEMIN5;YTHDC1;FYTTD1;SRSF4;SECISBP2L;XPO5;NOVA2;DXO;MARF1;PARK7;TARDBP;CPSF6;EIF4G2;NCBP3;DDX3X;NANOS3;RPS3;PTBP1;PCBP3;ACO1;G3BP2;RPL35;RNF20;SCAF8;DCP1A;SSB;RBM4B;SF3B6;PPP1R8;HNRNPL;NOCT;TRA2B;ADARB1;SLBP;TDRD7;UPF3B;RSL1D1;PURB;PARN;N4BP1;LARP4;CALR;EIF2S2;EIF3A;RPL26;LUC7L2;RC3H1;RPS2;NSRP1;EIF4G1;CLUH;MRPL13;DHX36;HNRNPM;LARP1;DCP1B
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3835097868778352,-0.9882117048339096,0.4646924829157175,0.7522570179150797,1.0,4/15,8.83%,WDFY3;SNAP91;EEA1;ZFYVE16
prerank,deubiquitinase activity (GO:0101005),-0.2533014686869502,-0.9881816647233992,0.45896656534954405,0.7487750529991396,1.0,35/88,23.52%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;EIF3F;COPS5;MYSM1;JOSD1;USP35;EIF3H;USP49;USP2;USP46;USP24
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4213636032661389,-0.9875892129250422,0.47433264887063653,0.7466734936135443,1.0,5/11,13.99%,SLC1A3;SLC6A13;SLC6A1;SLC6A12;SLC6A15
prerank,vinculin binding (GO:0017166),-0.4117482887145225,-0.9851957597702188,0.4793388429752066,0.7492584888178935,1.0,3/11,5.11%,CTNNA1;TLN1;PXN
prerank,phosphatidylglycerol binding (GO:1901611),0.40651301513513394,0.9851833239394814,0.46397188049209137,1.0,1.0,3/13,9.93%,MME;UQCC3;PITPNA
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.37050090555176995,-0.9835446248268205,0.4696969696969697,0.7465417433495065,1.0,9/16,40.33%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.37050090555176995,-0.9835446248268205,0.4696969696969697,0.7465417433495065,1.0,9/16,40.33%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,triglyceride lipase activity (GO:0004806),-0.34149629243013613,-0.98237298343078,0.47757847533632286,0.746077647685773,1.0,7/20,38.39%,ABHD5;LIPE;PLA2G15;DDHD2;PNPLA2;LPL;PNPLA3
prerank,transferrin receptor binding (GO:1990459),-0.4300629274787288,-0.9823062477984132,0.5020746887966805,0.7427689943464041,1.0,3/10,3.62%,SNX2;RGMA;SNX4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.23154923380459652,0.9821337006614044,0.5299055613850997,1.0,1.0,76/732,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;FOXN2;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;TBX1;ZNF260;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,microtubule plus-end binding (GO:0051010),0.37034072586612043,0.9819036772310951,0.4905008635578584,1.0,1.0,9/20,19.51%,KIF18A;CLASP2;DST;CLIP2;APC;CLIP1;CLASP1;PAFAH1B1;MAPRE3
prerank,small GTPase binding (GO:0031267),0.2597652880282253,0.9801154584199543,0.49195710455764075,1.0,1.0,46/169,16.31%,SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;CYRIB;MYO5A;CIB1;USP6NL;AP1G1;TRIP11;RABGAP1L;FGD5;RAPGEF6;XPO5;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;USP33;KIF3B;RABGAP1;AP3M1;ANKRD27;BICD2;RCC1;RUSC2;PPP6R1;TMEM127;RAB3GAP1;WHAMM;CDKL5;BRAF;DOCK4;EXOC2;DNM1L;ABI2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4462501376105832,0.9785960980752589,0.5116731517509727,1.0,1.0,4/10,14.60%,PIK3CG;PIK3C2G;PIK3CD;PIK3C2A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.37762239784565166,-0.9761487112786533,0.49665924276169265,0.7545342247518769,1.0,8/13,27.08%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH2;ADH5;ALDH9A1;ALDH1L2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4204166963997508,-0.974247202070999,0.5030927835051546,0.7555209015704439,1.0,5/10,19.80%,DLG4;SHISA6;IGSF11;SHANK2;SHANK1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4030150095760764,-0.9739319430963859,0.4816414686825054,0.7528264660998474,1.0,5/11,36.94%,SLC2A10;SLC5A3;SLC17A5;SLC5A11;SLC2A9
prerank,glutamate receptor binding (GO:0035254),-0.3585631565158013,-0.9731652712345776,0.480083857442348,0.7513961149419565,1.0,8/17,26.62%,DLG4;SYNDIG1;SHISA6;IGSF11;SHANK2;SHANK1;CAMK2A;HIP1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2586756816448296,0.9726355897491173,0.5019762845849802,1.0,1.0,40/147,17.58%,THG1L;TIAM1;VAV3;EEF1D;CYTH4;NUCB2;ITSN1;DENND5B;ARHGEF6;LAMTOR1;ARHGEF7;CCDC88C;RAPGEF3;DENND1A;ARHGEF18;RAPGEF5;FGD5;EIF2B3;RAPGEF6;DOCK9;MYCBP2;SBF2;PREX2;EEF1B2;EPS8L1;RGL2;ELMO1;ANKRD27;DENND4C;ARHGEF10;RCC1;DENND1B;DOCK8;RAB3GAP1;GAPVD1;DOCK4;RASGRF2;WDR41;RGL1;RCC1L
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3046701213221671,-0.9720522361435557,0.5062344139650873,0.7507644758596937,1.0,13/30,26.44%,ATP7A;SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC31A1;SLC39A8;SLC11A2;SLC39A7;SLC39A6;SLC25A28;SLC30A5;TTYH1
prerank,protein kinase binding (GO:0019901),0.23472434549271573,0.9710711266245681,0.5738255033557047,1.0,1.0,76/479,14.26%,FAM83B;RAC2;FRMD5;PRKAR1A;MAP2K7;MAP3K11;PTPRR;GSK3A;CKS2;TRIB3;DUSP7;PTPRJ;EEF1A1;OXSR1;PIN1;PTPRC;MTCP1;ACTB;RPTOR;TIRAP;HDAC7;HDAC9;RFFL;PRKD2;SMAD1;NEK9;CDK5RAP1;LRBA;RBBP6;SPRED1;DCTN2;TRIM14;CDKN1A;ARHGEF7;RGCC;CALM3;FBXO5;SIRT1;CADPS;AXIN1;TRPV4;PRAM1;PLCG1;ACVRL1;RELA;RAB11FIP2;POLA1;PJA2;PKN1;FBXO7;PPP1R12A;CIR1;RNF13;ESR1;BAD;RHOG;ADIPOR1;USP37;RPS3;NBR1;TNIP2;IKBKB;KIZ;CDH5;TBC1D14;ACTA2;CTBP2;HDAC5;PLEK;CHEK2;NEK6;FAF1;MAP2K6;APC;TRIM27;GCH1
prerank,nucleosomal DNA binding (GO:0031492),0.3659018285004131,0.9709417300722353,0.5035335689045937,1.0,1.0,8/21,19.09%,ACTL6A;ACTB;HNRNPC;RCC1;SMARCA4;RBBP4;HDAC2;SMARCB1
prerank,copper ion binding (GO:0005507),0.3121180822701838,0.970572721710323,0.5090311986863711,1.0,1.0,9/42,15.72%,SNCG;RNF7;SOD1;PARK7;PAM;PRNP;CUTC;S100A13;ANG
prerank,neuropeptide hormone activity (GO:0005184),0.3560705985804912,0.9694725803104305,0.5,1.0,1.0,22/22,64.44%,PPY;AGRP;OXT;CORT;QRFP;HCRT;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;NPFF;NPY;GRP;SPX;CCK;PENK;ADCYAP1
prerank,double-stranded DNA binding (GO:0003690),0.233321561043475,0.9688612013822636,0.5570032573289903,1.0,1.0,59/531,11.73%,SOX30;ATF3;IRX1;FOXQ1;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;LEF1;HES6;PNKP;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;HEY1;NR5A1;IRF9;PRDM4;MYBL2;FLI1;BBX;YY1;GMEB2;ZNF740;USF2;CPSF4;RFX3;TBX1;TDG;CEBPG;PPARD;ZNF638;CLOCK;HEY2;ZBTB14;SPRTN;JUND;HOXA7;PCID2;TFAP4;MSH3;ERG;PARK7;TARDBP;KLF6;ESR1;THRB;RAD51B;APTX;NFIC;RPS3;POLR3F;HDGF
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2505502384847122,-0.9684472478567877,0.47023809523809523,0.7561239006684392,1.0,34/83,24.44%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;COPS5;MYSM1;JOSD1;USP35;USP49;USP2;USP46;USP24;OTUD7B
prerank,kinase activator activity (GO:0019209),-0.30114135469860437,-0.9676940930346871,0.544529262086514,0.7544784550510851,1.0,9/30,16.72%,PRKAG2;WNK1;MALT1;CAB39;STRADA;STK11;MADD;RPLP1;GPRC5B
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.39811400212798265,0.9653790946587766,0.5075471698113208,1.0,1.0,1/15,0.29%,CISH
prerank,protein tyrosine kinase binding (GO:1990782),-0.25879438316295467,-0.9647505601927924,0.5425219941348973,0.7579160201250765,1.0,18/71,19.93%,GRM5;KHDRBS1;PTPN14;NEDD9;ACVR1;TP53;NOX4;PITPNM3;SIRPA;SHC3;DUSP22;RACK1;TOB1;PTPN2;SOCS5;ANGPT2;CPNE3;BMPR2
prerank,C-C chemokine binding (GO:0019957),-0.331718063966429,-0.9646824248977993,0.5079006772009029,0.7547437323436409,1.0,16/22,63.13%,CCR9;ACKR3;CX3CR1;ZFP36;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.4236110983559709,0.9639587360209113,0.5149812734082397,1.0,1.0,4/12,14.60%,PIK3CG;PIK3C2G;PIK3CD;PIK3C2A
prerank,calcium channel regulator activity (GO:0005246),-0.2881748699851983,-0.9638391044361264,0.4914004914004914,0.753564528527476,1.0,8/37,12.21%,ITPR1;STIM2;NRXN1;STIM1;SGK1;CACNG7;NRXN2;SRI
prerank,ATP hydrolysis activity (GO:0140603),0.3128429273384731,0.9632466537940592,0.5174603174603175,1.0,1.0,10/41,18.30%,ABCB10;RUVBL2;VWA8;RUVBL1;DDX3X;CHD3;MYO1E;TOR3A;VPS4B;MYO18A
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.40869133893845144,0.9606477622035146,0.5343511450381679,1.0,1.0,6/12,20.15%,NCBP1;GEMIN5;NCBP3;CYFIP1;LARP1;EIF4E
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.22630116716027618,0.959613714717523,0.615546218487395,1.0,1.0,75/731,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;TBX1;ZNF260;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,phospholipase activity (GO:0004620),0.292464593897998,0.9579440953654931,0.5311572700296736,1.0,1.0,10/67,14.23%,FAM83B;SMPD4;PLAAT3;PNPLA7;SEC23IP;DDHD1;PNPLA8;ABHD12;ABHD4;PNPLA6
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.37452584420447627,0.9548233230838296,0.5111111111111111,1.0,1.0,1/18,0.29%,CISH
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.3489170379113301,-0.9528390418684942,0.5239179954441914,0.7763462913879422,1.0,4/15,12.10%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1
prerank,lipoprotein particle binding (GO:0071813),-0.32923313385034364,-0.9528270917084811,0.5268817204301075,0.7730277119172886,1.0,6/20,18.47%,MAPT;SORL1;LDLR;THBS1;HSPD1;SCARF1
prerank,NAD binding (GO:0051287),-0.30914173537606365,-0.9513508855813624,0.5283505154639175,0.7731893871092385,1.0,5/26,7.04%,ALDH1A1;ME1;ZC3HAV1;SIRT2;GLUD1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.31324349742400565,-0.9509217302920124,0.5214285714285715,0.7708103341620058,1.0,10/24,27.64%,CAMK4;PHKA2;CAMK2D;CAMK1;DAPK1;PHKG2;MKNK2;CAMK2B;CAMK2A;MAPKAPK2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34709702140103804,0.9507561241950956,0.5178875638841567,1.0,1.0,5/24,16.52%,PPIP5K2;NME1;IP6K2;DTYMK;ITPKB
prerank,sialyltransferase activity (GO:0008373),0.36077986842363374,0.949394378286037,0.5277777777777778,1.0,1.0,6/20,14.61%,ST6GALNAC3;ST8SIA1;ST3GAL6;ST3GAL1;ST6GALNAC2;ST8SIA6
prerank,protein heterodimerization activity (GO:0046982),0.24938168725374954,0.9488215069704558,0.5714285714285714,1.0,1.0,33/178,14.66%,MIGA1;ATF3;SIM1;NR4A2;ATF6;SAE1;BCL2L2;ZHX3;PPP2CA;RALGAPA2;EXT2;PHB2;USF2;FXR1;RALGAPB;UBA2;SNX1;FZD9;FBXO7;NAE1;GTF2A2;ITGA3;IKBKB;CHUK;TPM2;RRAGC;YWHAH;TENM4;EPAS1;DDIT3;RALGAPA1;CYBA;RCC1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.2937707271671059,0.948707407459467,0.5331179321486268,1.0,1.0,14/53,17.98%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC17A6;SLC1A2;SLC25A2;SFXN1;SLC25A12;SLC38A5;SLC66A1;SLC25A38;SLC7A5;SLC43A2
prerank,DNA replication origin binding (GO:0003688),0.35118593996125097,0.9486770938620122,0.5282051282051282,1.0,1.0,5/23,11.47%,ORC3;CDC45;ORC4;POLA1;ORC2
prerank,SH3 domain binding (GO:0017124),0.2904633858501143,0.9478835127490294,0.5236686390532544,1.0,1.0,16/62,17.02%,CBL;VASP;CABYR;SHANK3;EVL;SGIP1;PTPN12;REPS1;SYNJ2;ELMO1;CYBA;RUFY1;ABI2;ARHGAP27;CD2AP;ADAM9
prerank,voltage-gated chloride channel activity (GO:0005247),-0.40098883237461425,-0.9463435961461433,0.5263157894736842,0.7783180352269908,1.0,4/10,14.22%,CLCN6;ANO1;CLCN2;ANO6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2934949073107495,0.9424327786657551,0.5486322188449848,1.0,1.0,10/54,13.21%,AMDHD2;ACER2;GLS2;GLS;HDAC9;HDAC3;SIRT1;NADSYN1;ACER3;HDAC5
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.22134701548064564,0.941822380970842,0.7018828451882845,1.0,1.0,84/831,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;SIM1;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;STOX1;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;BBX;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;ZSCAN2;VEZF1;RFX3;TBX1;ZNF260;NFX1;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;ACTN4;CLOCK;ZNF3;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;TRPS1;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.23816745251615784,0.9400265422578755,0.6063569682151589,1.0,1.0,50/232,17.71%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEDD4L;NEURL2;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;RFWD3;MYCBP2;PIAS2;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;PIAS1;DTX4;RNF11;CUL3;RNF216;RNF180;TRIM27;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1;RNF215
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.36801753816366184,-0.9377815854431693,0.5252100840336135,0.7954545427026216,1.0,6/13,27.39%,GPSM1;GDI1;ARHGDIA;ARHGDIB;ITGB1BP1;SH3BP4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.37230604910214415,0.9372824371867713,0.5285451197053407,1.0,1.0,6/16,18.04%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.37230604910214415,0.9372824371867713,0.5285451197053407,1.0,1.0,6/16,18.04%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3039185541519097,-0.9369017499456939,0.5323383084577115,0.7941716611627742,1.0,5/29,6.59%,SLC13A3;SLC26A7;SLC1A5;SLC25A13;SLC26A2
prerank,C-C chemokine receptor activity (GO:0016493),-0.32818880504526843,-0.9362785754941185,0.5730088495575221,0.7921374139737021,1.0,15/21,63.13%,CCR9;ACKR3;CX3CR1;CCR5;CCR2;CXCR4;GPR75;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,peptidase activator activity (GO:0016504),-0.32358237117897104,-0.9360828482408956,0.5601750547045952,0.78924724627078,1.0,15/22,34.71%,CASP8AP2;VCP;PCOLCE2;PSME4;PCOLCE;EBAG9;TANK;PINK1;APH1B;CLPX;PSME2;PSME3;CAV1;PSME1;PSENEN
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.38735854598880315,-0.9354331644446583,0.5341614906832298,0.7874287911442998,1.0,2/11,14.14%,SLC22A4;SLC25A47
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.35180292712112404,-0.9350574002658134,0.5536105032822757,0.784995928121566,1.0,6/16,20.90%,MTMR7;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11
prerank,steroid hydroxylase activity (GO:0008395),-0.35352303920673195,-0.9342863173815995,0.5564853556485355,0.7835338030338712,1.0,2/16,5.93%,CYP27A1;CYP7B1
prerank,lysine-acetylated histone binding (GO:0070577),-0.3218456043556508,-0.9331701017565788,0.54,0.7797471858978523,1.0,6/20,12.95%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,acetylation-dependent protein binding (GO:0140033),-0.3218456043556508,-0.9331701017565788,0.54,0.7797471858978523,1.0,6/20,12.95%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3055283925575255,0.9326986351944445,0.5735537190082645,1.0,1.0,5/42,9.02%,CKS2;CCNC;CCNH;CDKN1A;CCNG2
prerank,carboxylic acid binding (GO:0031406),0.31227232876937694,0.9322069870937831,0.5679389312977099,1.0,1.0,2/38,0.78%,PCK1;GCLC
prerank,histone acetyltransferase binding (GO:0035035),-0.32796454164385114,-0.9319692973095016,0.547945205479452,0.7791134909282104,1.0,6/21,19.51%,GLI3;KANSL1L;SIRT2;TP53;EID1;STAT1
prerank,voltage-gated anion channel activity (GO:0008308),0.37933333395879487,0.931846681903704,0.5595026642984015,1.0,1.0,3/15,5.58%,CLCN3;GPR89A;GPR89B
prerank,exopeptidase activity (GO:0008238),-0.2586006295182072,-0.9318214023431808,0.599483204134367,0.7762589928057554,1.0,16/50,21.14%,DPP6;RNPEP;TRHDE;DPP4;ANPEP;FAP;DPP10;CPM;CTSA;NAALAD2;CTSZ;LAP3;ACE;ENPEP;DPP3;GGH
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3272253169481809,-0.929979575932051,0.5930735930735931,0.7773578437153845,1.0,4/20,5.78%,LPGAT1;AGPAT4;ABHD5;AGPAT5
prerank,ubiquitin protein ligase activity (GO:0061630),0.23425281575530088,0.9273095105788005,0.6371359223300971,1.0,1.0,48/228,17.71%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEDD4L;NEURL2;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;RFWD3;MYCBP2;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;DTX4;RNF11;CUL3;RNF216;RNF180;TRIM27;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1;RNF215
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3539352081192297,-0.923629454803848,0.5544147843942505,0.788502508917236,1.0,3/14,5.65%,SLC7A11;SLC1A3;SLC25A13
prerank,mannose binding (GO:0005537),0.3986111538322858,0.9232679384781847,0.5557729941291585,1.0,1.0,1/12,4.27%,LMAN2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.39545846875384716,-0.9231528459698289,0.5770065075921909,0.7864156881094838,1.0,3/10,4.57%,PRKAG2;PKIG;PRKAG1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.39324973215294867,-0.9224372893018136,0.5410526315789473,0.7849098477826454,1.0,8/10,38.80%,FAN1;DNAJC2;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,transcription cis-regulatory region binding (GO:0000976),0.22375514159334706,0.9212785534129272,0.695752009184845,1.0,1.0,58/406,14.28%,ATF3;CTCFL;DACH1;SIM1;ARID5A;FOXN2;TFCP2;MTERF3;TAL1;ATF6;LEF1;ELK3;STOX1;PAX8;GABPA;NR5A1;MMP12;FLI1;BBX;SMARCA2;SOX2;YY1;ZSCAN2;VEZF1;RFX3;NFX1;CALCOCO1;FOXF2;SFPQ;LONP1;ACTN4;DRAP1;ZNF3;ZBTB14;SOX13;RELA;XRN2;JUND;TFAP4;PARK7;TRPS1;CARM1;RPS3;ZBED4;E2F3;SP1;MZF1;IRF2;CHD3;TBP;HDAC5;EPAS1;DDIT3;THRA;CREBRF;DR1;GRHL1;PURG
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.2596981612150665,-0.9172940428094108,0.6176470588235294,0.7933115367288712,1.0,14/51,18.17%,SLCO3A1;MCU;SLC22A8;ANKH;SLC25A3;SLC22A4;SLC20A1;TMEM241;SLC35D2;SLC22A6;SLC16A2;SLC16A10;SLC5A6;SLC5A5
prerank,histone deacetylase binding (GO:0042826),0.263371132721289,0.9172372721413992,0.6101449275362318,1.0,1.0,16/88,13.92%,TAL1;LEF1;HDAC9;HDAC3;MAPK8;YWHAB;SFPQ;HEY2;RELA;TFAP4;PKN1;AKAP8L;CIR1;SP1;HDAC5;HES1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2919602643212915,-0.9163320550685906,0.589622641509434,0.7923120327267598,1.0,17/28,43.08%,PRORP;AGO3;DICER1;ELAC1;RPP30;RPP14;DROSHA;RPP21;DBR1;EDC3;RNASEH2A;ELAC2;POP4;RPP38;NUDT16;NUDT16L1;MRPL44
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.39016482495022015,-0.915988526732297,0.5755102040816327,0.7900326139088729,1.0,2/10,14.26%,SLCO3A1;SLC22A6
prerank,N-methyltransferase activity (GO:0008170),0.34921362907590536,0.9137646339188997,0.5859519408502772,1.0,1.0,4/20,13.15%,TRMO;TRMT11;SETD3;RNMT
prerank,palmitoyltransferase activity (GO:0016409),0.3224407939167902,0.913035117524542,0.5806988352745425,1.0,1.0,6/28,14.05%,ZDHHC17;ZDHHC13;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,androgen receptor binding (GO:0050681),-0.30553954163323904,-0.9122364826032154,0.6123853211009175,0.7952814500216091,1.0,5/25,8.52%,DDX5;FOXP1;RNF14;WIPI1;SNW1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24392145066798226,-0.9100758501578057,0.6535947712418301,0.7967763604242656,1.0,24/74,23.06%,DGKI;NADK2;PIK3C2B;GK;NADK;DCAKD;PIK3C3;DGKH;PANK3;FAM20C;ADK;PKM;CHKA;AGK;FAM20A;PAPSS2;NT5C3A;IDNK;HYKK;NOL9;DGKQ;HK2;CHKB;RFK
prerank,calcium ion binding (GO:0005509),0.22646920165472265,0.9098690335353782,0.7050528789659224,1.0,1.0,43/323,12.63%,SPOCK2;EFHD2;LCP1;EML1;SLC25A24;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;LTBP4;MEX3B;ATP2A2;CDH2;ITSN1;ESYT2;MMP12;EFHD1;SDF4;RASGRP3;CIB1;RET;SELP;MCTP2;CALM3;CDH12;RCN2;AIF1L;S100A16;TRPM4;MCTP1;ACER3;PAM;PPP3CA;PRNP;PPP3R1;AGRN;MICU3;LETM1;IDS;SLC25A12;CDH5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3864030098177157,0.9074963041135236,0.5958646616541353,1.0,1.0,4/12,14.37%,BCL2L13;BAD;NOD1;APAF1
prerank,gamma-tubulin binding (GO:0043015),0.3373778619344949,0.9060159144353019,0.5992647058823529,1.0,1.0,5/21,10.80%,TUBGCP5;ARHGEF7;RAB11FIP5;PAK1;DDX3X
prerank,nuclear localization sequence binding (GO:0008139),0.35363635132280485,0.9041730912646372,0.5953237410071942,1.0,1.0,7/18,20.50%,KPNA3;KPNA1;NFKBIA;KPNB1;POM121;BRAP;RANBP6
prerank,sodium channel regulator activity (GO:0017080),0.2955622583613765,0.9035474339496465,0.5815831987075929,1.0,1.0,4/37,6.33%,RSC1A1;NEDD4L;FXYD6;FGF13
prerank,sterol binding (GO:0032934),-0.2505632661645424,-0.9035371861230134,0.6684931506849315,0.8077834221811111,1.0,15/56,15.12%,OSBPL9;GRAMD1B;OSBPL11;OSBPL6;SIDT1;VDAC1;GRAMD1C;OSBP;INSIG2;OSBPL5;ABCA1;RORA;OSBP2;STARD5;GRAMD1A
prerank,translation initiation factor activity (GO:0003743),0.29746732069167525,0.9025865174472617,0.610648918469218,1.0,1.0,13/36,20.22%,EIF2S1;EIF2A;EIF3B;EIF2B3;EIF4G2;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1;EIF3E;EIF4E;EIF1
prerank,mannosyltransferase activity (GO:0000030),0.3353817559583266,0.9022447839785119,0.6077057793345009,1.0,1.0,5/21,11.30%,TMTC2;DPY19L4;ALG8;DPY19L1;PIGB
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.23163612133647604,-0.8990584187164317,0.6891025641025641,0.8141633983225648,1.0,6/73,6.20%,SORCS1;CALCRL;LGR4;SORCS3;NPR3;EDNRA
prerank,metalloaminopeptidase activity (GO:0070006),0.36427852007870554,0.8989758206461098,0.581081081081081,1.0,1.0,1/16,0.22%,LVRN
prerank,MAP kinase activity (GO:0004707),0.36944766691623115,0.8989031049958572,0.5970961887477314,1.0,1.0,5/14,12.70%,MAPK3;MAPK8;NLK;MAPK6;MAPK12
prerank,serine-type endopeptidase activity (GO:0004252),0.2602138843734622,0.8974676146721948,0.6436950146627566,1.0,1.0,2/80,0.59%,PCSK1;CELA1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.37612444750446794,-0.8958337869528719,0.6032388663967612,0.8180919900757594,1.0,5/11,10.94%,RAD50;HNRNPA2B1;STN1;RPA1;HNRNPA1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3391620760663046,-0.8953563845411165,0.6131868131868132,0.8159985430773028,1.0,8/15,38.36%,PLA2G4A;SNX3;SAP30L;SH3PXD2B;PLEKHF1;JPH2;PLA2G4E;PHLDA3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.3909424451153585,-0.8948132255267048,0.6188679245283019,0.813989723762304,1.0,1/10,1.62%,DPYSL3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3207725065083089,0.8942794165215119,0.6038732394366197,1.0,1.0,6/26,15.44%,SAG;BOD1;PPP1R11;MGAT5;CABIN1;PPP1R8
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3026542813552407,0.8916566273425302,0.6398104265402843,1.0,1.0,6/35,10.62%,SRC;FYN;SYK;PEAK1;LYN;YES1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3345336430410253,0.8911191828830315,0.6152450090744102,1.0,1.0,4/21,9.15%,CDK19;CDK11B;CDK4;CDKL4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3345336430410253,0.8911191828830315,0.6152450090744102,1.0,1.0,4/21,9.15%,CDK19;CDK11B;CDK4;CDKL4
prerank,Notch binding (GO:0005112),-0.3026061243358769,-0.8907087353423555,0.5976470588235294,0.8193618019401169,1.0,5/22,16.37%,SNED1;DNER;SNW1;MEGF10;CCN3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.2884671277351342,-0.8894959811089695,0.6252873563218391,0.8187614069543819,1.0,6/28,19.51%,EDA;CASP8AP2;MADD;TRAF2;TMBIM1;STAT1
prerank,neuropeptide receptor activity (GO:0008188),0.310768965012183,0.8887547702736821,0.6192893401015228,1.0,1.0,2/29,2.09%,NPFFR1;TACR1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3935620126754016,0.8873974060047842,0.6084452975047985,1.0,1.0,1/11,0.80%,MAP3K11
prerank,anion transmembrane transporter activity (GO:0008509),-0.3672728067441818,-0.8866019869363331,0.6090712742980562,0.8216465922284797,1.0,5/12,15.92%,SLC39A8;SLC22A6;SLC26A11;SLC4A2;SLC19A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.3762233514617056,0.8858714410082045,0.6,1.0,1.0,3/12,17.17%,PDE4D;PDE8B;PDE8A
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2948817323122457,-0.8855069394709797,0.6579572446555819,0.8208267192871802,1.0,5/27,12.26%,LRP1;RELN;HSPG2;AP2A1;MESD
prerank,cytokine receptor binding (GO:0005126),-0.22814518213792961,-0.8853869122801078,0.7291666666666666,0.8179351085812984,1.0,11/83,13.88%,TGFBR3;SMAD3;JAK1;OSMR;IL6R;PIBF1;IL34;IL13RA1;SOCS2;IL18;IL6ST
prerank,calcium:sodium antiporter activity (GO:0005432),-0.37480844281958714,-0.8850674053830311,0.6335403726708074,0.815537379981946,1.0,2/10,9.99%,SLC24A3;SLC24A2
prerank,protein phosphatase activator activity (GO:0072542),0.3719031985609439,0.8849490305379326,0.6190476190476191,1.0,1.0,6/13,21.18%,CALM3;PTPA;PPP2R5A;CALM1;PPP2R5C;PHACTR4
prerank,NF-kappaB binding (GO:0051059),0.32336684358931395,0.8848911740726183,0.6395147313691508,1.0,1.0,9/24,18.38%,HDAC3;EP300;RELA;RNF25;TAF4B;FAF1;NFKBIA;NPM1;HDAC2
prerank,kinase activity (GO:0016301),0.24414196034179125,0.8841088227583268,0.6926286509040334,1.0,1.0,26/109,18.05%,PIK3CG;PPIP5K2;TRIB3;DGKB;PIK3C2G;PANK2;CERKL;LYN;ETNK1;PI4KA;PIK3CD;IP6K2;MAP4K4;TRRAP;PAPSS1;PIK3C2A;PGM2L1;CDKL5;TAF1;CERK;ITPKB;PANK1;PANK4;SEPHS1;DGKK;ADPGK
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.32685085368097233,0.8836208606663628,0.6243567753001715,1.0,1.0,5/24,14.05%,ZDHHC17;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,protein kinase regulator activity (GO:0019887),-0.22147668394303568,-0.8833407338402541,0.7655172413793103,0.8160627113282636,1.0,20/95,15.07%,PRKAG2;CCNL2;PARVA;DNAJC3;ELP4;WNK1;PRKAG1;GMFB;TAOK3;CAB39;CDKN1B;CCND3;STRADA;STK11;PRKAR1B;CCNT1;DUS2;MADD;RPLP1;CCNK
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3843895809024576,0.882364116484603,0.6094339622641509,1.0,1.0,2/11,11.52%,APLF;RPS3
prerank,chemokine activity (GO:0008009),0.30106666531990034,0.8819754193043139,0.6324786324786325,1.0,1.0,2/31,8.51%,CXCL12;CCL25
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3158555729984301,-0.879340173964552,0.6183035714285714,0.821148098169633,1.0,17/18,68.45%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.22857914487810013,0.8792594213054684,0.7377260981912145,1.0,1.0,30/188,14.06%,ATF3;CTCFL;ARID5A;MTERF3;TAL1;ATF6;PAX8;GABPA;FLI1;SMARCA2;SOX2;YY1;RFX3;CALCOCO1;SFPQ;ZBTB14;SOX13;RELA;JUND;TFAP4;CARM1;ZBED4;SP1;MZF1;CHD3;TBP;HDAC5;DDIT3;THRA;GRHL1
prerank,manganese ion binding (GO:0030145),0.28079540860699814,0.8783952948730781,0.6591639871382636,1.0,1.0,9/48,15.50%,PCK1;GYG1;PIM1;SOD2;EXD2;PAPOLA;MGAT5;IMPA1;DYRK2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.30244656049870794,0.8780179528272771,0.6430976430976431,1.0,1.0,9/32,18.00%,JMJD4;ALKBH2;KDM2A;TET3;EGLN2;PHF8;FTO;TET2;KDM4C
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.26790792117317075,0.8777882683839515,0.6609907120743034,1.0,1.0,14/57,14.41%,NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;NDUFB7;COX15;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,ribonuclease activity (GO:0004540),0.2715491755578314,0.8758675920011216,0.6485225505443235,1.0,1.0,18/56,20.97%,ZC3H12D;RNASE6;CNOT7;EXOSC9;RNASE12;CNOT6;EXOSC1;PPP1R8;ANG;RNASE4;N4BP1;SMG6;TSNAX;DIS3L2;EXOSC7;AGO1;ERN1;RNASE1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.34220406807617343,-0.8739738501263646,0.63718820861678,0.8291531303926342,1.0,3/15,27.00%,CCR9;CMKLR1;CX3CR1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3598277786885408,0.8724347542175351,0.6124763705103969,1.0,1.0,2/12,8.99%,TRAF5;TRAF3
prerank,transcription coactivator binding (GO:0001223),0.3252626438969027,0.8711193950445453,0.6378986866791745,1.0,1.0,6/20,10.75%,RPL23;PPARD;RELA;ESR1;TERT;THRB
prerank,diacylglycerol kinase activity (GO:0004143),-0.362559126442542,-0.8711027187067271,0.6610169491525424,0.8319676050303181,1.0,3/11,12.49%,DGKI;DGKH;AGK
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2433149176627027,-0.8700425451515263,0.7333333333333333,0.8310257851664234,1.0,13/49,20.57%,ATP1A2;MPPED2;PLCXD3;SACM1L;DUSP16;FRA10AC1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;LHPP;SBF1
prerank,phosphotyrosine residue binding (GO:0001784),0.2928333866368107,0.8699958812733406,0.653910149750416,1.0,1.0,10/37,18.42%,BCAR3;PFN1;SAMSN1;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1
prerank,cholesterol binding (GO:0015485),0.2763657282892436,0.8699672610888806,0.6645264847512039,1.0,1.0,11/47,13.80%,PROM1;OSBPL10;TSPO;SOAT1;OSBPL1A;CD81;ERLIN2;STARD3NL;NPC2;NPC1;OSBPL2
prerank,single-stranded DNA binding (GO:0003697),0.24813995553225532,0.8680287551539843,0.7203389830508474,1.0,1.0,17/93,12.85%,CTC1;PCBP1;ERCC4;SSBP1;PMS2;CDC45;LONP1;MLH1;SPRTN;POLA1;RAD23A;MSH3;PARK7;RAD51B;APTX;TOP3A;NUP35
prerank,exoribonuclease activity (GO:0004532),0.3677291554226613,0.8670456505400236,0.6346153846153846,1.0,1.0,4/12,13.16%,CNOT7;EXOSC9;CNOT6;EXOSC1
prerank,MHC protein binding (GO:0042287),0.32510503767519466,0.8665586950499399,0.6402877697841727,1.0,1.0,5/20,20.10%,TUBB;CD81;ATP5F1B;DERL1;TAP2
prerank,aminopeptidase activity (GO:0004177),0.31219055866801804,0.866130933759748,0.6577540106951871,1.0,1.0,2/26,5.07%,LVRN;METAP2
prerank,cytokine activity (GO:0005125),-0.20657347132997547,-0.8617202265965248,0.8350877192982457,0.844167019325716,1.0,22/131,24.21%,BMP6;WNT5B;BMP5;BMP7;BMP4;IL34;WNT4;AIMP1;IL16;WNT9A;CCL14;IL18;IL33;TNFRSF11B;TGFB1;SCG2;CX3CL1;CCL13;VEGFA;IL17D;CKLF;TGFB3
prerank,heme binding (GO:0020037),0.2556242509386362,0.8601009760793736,0.7079510703363915,1.0,1.0,9/65,11.55%,HMOX2;CYCS;PTGES2;SRC;THAP4;CYB5R4;CYP1B1;NOS3;COX15
prerank,mechanosensitive ion channel activity (GO:0008381),-0.35539348776147145,-0.8599905898459601,0.673036093418259,0.8444532217363364,1.0,5/12,28.80%,PIEZO2;TMEM63A;TMEM63B;TMC4;TMC6
prerank,RNA stem-loop binding (GO:0035613),0.36244756392413,0.8599025923870758,0.6647286821705426,1.0,1.0,7/12,24.37%,DDX3X;RC3H1;DHX9;RC3H2;FMR1;MYH10;CPEB3
prerank,SUMO binding (GO:0032183),-0.33963535570555065,-0.8590300534421168,0.6618556701030928,0.8432467744059582,1.0,4/13,9.20%,CASP8AP2;PML;RNF4;USPL1
prerank,signal sequence binding (GO:0005048),0.28578466953970993,0.8566741205805904,0.6650326797385621,1.0,1.0,9/35,17.46%,TOMM20;KPNA3;KDELR2;KPNA1;SEC61A2;NFKBIA;AP2M1;KPNB1;POM121
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3524107629346811,0.8550007410323684,0.6525252525252525,1.0,1.0,4/15,12.49%,SLC1A1;SLC17A6;SLC1A2;SLC25A12
prerank,tau-protein kinase activity (GO:0050321),0.327473239075048,0.8545299669594232,0.6744186046511628,1.0,1.0,3/20,6.68%,GSK3A;FYN;SIK3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3032829455256873,0.85346535342987,0.6573426573426573,1.0,1.0,8/27,16.97%,ARIH1;DCUN1D4;AUP1;UBE3D;RNF180;RNF125;DCUN1D2;DCUN1D1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3449228754839428,0.8532685389299063,0.6217712177121771,1.0,1.0,3/15,8.69%,NDST3;HS6ST1;HS3ST2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.3202443068713295,0.8527024694530064,0.6877256317689531,1.0,1.0,5/22,14.38%,APOE;SNX17;PICALM;LDLRAP1;AP2M1
prerank,histone deacetylase activity (GO:0004407),0.33197885123156146,0.8510095284630692,0.6887661141804788,1.0,1.0,4/19,7.29%,HDAC9;HDAC3;SIRT3;SIRT1
prerank,ankyrin binding (GO:0030506),0.32661813422729835,0.850365235777848,0.6672794117647058,1.0,1.0,2/19,2.03%,SPTB;PTPRC
prerank,mitogen-activated protein kinase binding (GO:0051019),0.2984443532403778,0.8479372954116757,0.6836555360281195,1.0,1.0,5/29,14.26%,DUSP7;PTPRJ;SIRT1;NBR1;GCH1
prerank,hexosyltransferase activity (GO:0016758),0.2354371816657904,0.847237517046704,0.7514285714285714,1.0,1.0,8/101,4.62%,CSGALNACT1;GYG1;TMTC2;CHSY3;POMGNT2;EXT2;ALG6;DPY19L4
prerank,phosphatidylinositol binding (GO:0035091),0.24536243435352137,0.84653817962828,0.757162346521146,1.0,1.0,23/91,16.72%,EXOC8;MCF2L;SNX8;ESYT2;PLEKHF2;DENND1A;SNX17;EPB41;WDFY1;SNX1;PITPNA;ING2;ZFYVE9;SCARB1;PICALM;MYO1E;SNX24;AIDA;PARD3;DENND1B;PIGU;SNX16;ZFYVE1
prerank,protein kinase C binding (GO:0005080),0.2756320454775012,0.8461139806509997,0.7063621533442088,1.0,1.0,8/43,13.32%,TIRAP;HDAC7;HDAC9;PRKD2;TRPV4;PKN1;HDAC5;PLEK
prerank,methyl-CpG binding (GO:0008327),0.3118693567826015,0.8439935341828904,0.6903914590747331,1.0,1.0,4/22,11.13%,ZBTB33;CHTOP;TET3;ERH
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.29163474881835827,-0.8438743198143858,0.6863636363636364,0.8686812314853999,1.0,2/21,4.75%,GLRB;P2RX4
prerank,phospholipid transfer activity (GO:0120014),0.3262826540916275,0.8424842936382434,0.687037037037037,1.0,1.0,8/21,19.03%,PRELID3B;PRELID2;PITPNA;OSBPL2;CERT1;PLEKHA3;PITPNB;PLTP
prerank,DNA polymerase binding (GO:0070182),0.32166754116518675,0.8420518335179616,0.6637931034482759,1.0,1.0,7/18,20.74%,LONP1;ACD;CDK2AP1;SMARCA4;SMG6;PTGES3;HSP90AB1
prerank,protein phosphatase regulator activity (GO:0019888),0.2559697857749454,0.8356071653679297,0.7342549923195084,1.0,1.0,18/53,20.27%,SAG;PPP2R2D;BOD1;PPP1R16B;CALM3;RCAN2;ANKLE2;MGAT5;CABIN1;PTPA;PPP6R1;PPP2R3A;PPP2R5A;CALM1;IGBP1;PPP2R5C;PPP1R2;RCAN3
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3590655898914373,-0.8345250302048479,0.6845238095238095,0.8831774657843214,1.0,5/10,15.51%,DPP6;DPP4;FAP;DPP10;NAALAD2
prerank,protein phosphatase 2A binding (GO:0051721),0.30197419378430684,0.8343628280051761,0.6994633273703041,1.0,1.0,10/23,20.21%,BOD1;MFHAS1;ANKLE2;CTTNBP2NL;STRN4;PTPA;SMG5;IGBP1;SMG7;STRN3
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.2807388131403565,0.8343614470588249,0.7088815789473685,1.0,1.0,11/35,17.31%,RUVBL2;MMP12;DRAP1;RELA;PARK7;TBP;DR1;BAZ2A;TAF1;SMARCA4;NPM1
prerank,alpha-tubulin binding (GO:0043014),0.2854900565551791,0.8336964294310298,0.722027972027972,1.0,1.0,9/31,16.70%,FYN;DIP2B;DNAL1;TRPV4;TBCEL;TTLL7;EFHC2;INO80;SETD2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.34318067189002127,0.8326774542677222,0.686456400742115,1.0,1.0,3/14,15.71%,RDH11;RDH10;AKR1A1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.3238354789015433,0.8323169845410462,0.6912028725314183,0.9994649141355406,1.0,2/18,3.83%,RPS6KA1;BIRC2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.32715224227138506,-0.8320478240566227,0.7089715536105032,0.8846845065810812,1.0,5/14,20.90%,MTMR7;MTMR12;MTMR9;MTMR4;MTMR11
prerank,gated channel activity (GO:0022836),0.34683474361254385,0.8306030836579392,0.676950998185118,0.9992072546421992,1.0,2/14,8.37%,TMEM266;TMC7
prerank,channel activity (GO:0015267),-0.24783527467236624,-0.8300958239292784,0.7682926829268293,0.8848522294463894,1.0,11/41,26.66%,PDPN;AQP4;MPV17;TMEM120B;BCL2;MCUB;TMEM120A;PANX1;AQP11;CHRNA7;TRPV2
prerank,DNA-binding transcription factor binding (GO:0140297),0.21553750518166565,0.8298266949027245,0.8291139240506329,0.9969438388717938,1.0,39/189,16.21%,CHCHD2;TAL1;HES6;DMAP1;HIPK2;HDAC7;HDAC9;GABPA;USF2;EP300;PPARD;SIRT1;HEY2;RELA;PIAS2;PARK7;LMO2;RBPJ;CREBBP;CTBP1;TLE4;PIAS1;IFI27;SP1;NBN;TBP;RERE;HDAC5;DDIT3;NEK6;HES1;HCFC1;CRTC3;MAP3K10;TCERG1;TAF1;ID2;TCF3;PURB
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2574606091703634,-0.8296371703607771,0.7780612244897959,0.8824946692262559,1.0,12/34,21.33%,IQGAP1;CAB39;MAP2K2;STRADA;CCNT1;TAOK1;FAM20A;IGF2;CCNK;IRGM;PARP16;ETAA1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.2641528680432065,-0.8258024834141833,0.7494145199063232,0.8863633238662838,1.0,10/31,26.78%,UBE2N;UBE2E1;UBE2J2;UBE2J1;UBE2K;UBE2Q1;UBE2B;UBE2E2;UBE2S;UBE2G2
prerank,telomerase RNA binding (GO:0070034),0.30645451228502657,0.8204851531564211,0.7022375215146299,1.0,1.0,9/22,19.90%,HNRNPC;TERT;DKC1;PARN;SMG6;SMG5;SNRPD3;DHX36;SMG7
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3573453763562431,0.818625564211217,0.6871508379888268,1.0,1.0,2/11,5.22%,MAP3K7;MAP3K4
prerank,RNA cap binding (GO:0000339),0.322634677035643,0.817495253275029,0.70817843866171,1.0,1.0,7/16,20.15%,NCBP1;GEMIN5;NCBP3;CYFIP1;LSM1;LARP1;EIF4E
prerank,phosphatase inhibitor activity (GO:0019212),0.3067888132880504,0.816593937354095,0.7092592592592593,1.0,1.0,4/20,13.52%,SAG;BOD1;MGAT5;CABIN1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2861885368783278,-0.8149110374887225,0.7659090909090909,0.9025736499247492,1.0,7/20,23.28%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;SETD4;METTL21A
prerank,protein phosphatase 1 binding (GO:0008157),0.3031150821861559,0.8139884277522342,0.7307001795332136,1.0,1.0,3/21,12.34%,PPP1R16B;PPP1R11;AKAP11
prerank,calcium activated cation channel activity (GO:0005227),-0.2940546927911547,-0.8118654848132647,0.7542735042735043,0.9048108761567596,1.0,6/17,18.70%,KCNMA1;ANO1;TMEM63A;ANO6;TMEM63B;ANO10
prerank,histone demethylase activity (GO:0032452),0.29032237150430373,0.8083378263384803,0.7464539007092199,1.0,1.0,7/27,14.24%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,sulfotransferase activity (GO:0008146),-0.24905576968230525,-0.8054292673253235,0.7960199004975125,0.9127691796142917,1.0,4/33,10.38%,UST;HS3ST3A1;CHST15;CHST11
prerank,O-methyltransferase activity (GO:0008171),0.35766141072319535,0.8047347364265205,0.6929133858267716,1.0,1.0,1/10,2.25%,BCDIN3D
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.2291476123061507,-0.8029689330121851,0.8196286472148541,0.9140792034574141,1.0,9/46,19.34%,MGAT4C;OGT;HEXA;HEXB;LARGE1;B3GALT5;B3GALNT1;B3GALT1;PIGA
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.34139796103801834,0.8014573274628006,0.7044145873320538,1.0,1.0,6/12,19.49%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,iron ion binding (GO:0005506),-0.23186399882324324,-0.8009343700188464,0.8172323759791122,0.9143668794626376,1.0,20/48,31.03%,AGMO;AOX1;DNAJC24;TET1;KDM7A;FTL;NFU1;PHYH;FDX1;EGLN3;PHF2;CDO1;JMJD6;ABCE1;EGLN1;HIF1AN;SNCA;ETHE1;FXN;SCD
prerank,ADP binding (GO:0043531),-0.2651166590636295,-0.8008777532756587,0.7600950118764845,0.9112393311291519,1.0,4/25,7.04%,PRKAG2;ME1;PRKAG1;GLUD1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3305967804144605,0.7990336157567075,0.7245080500894454,1.0,1.0,3/14,14.46%,CYB5R4;AIFM1;CYBA
prerank,nucleotide diphosphatase activity (GO:0004551),0.3301451843507598,0.7988581095169954,0.7115384615384616,1.0,1.0,2/14,3.90%,NUDT11;NUDT12
prerank,methyltransferase activity (GO:0008168),0.2535821050160375,0.7987682009575495,0.7853658536585366,1.0,1.0,12/46,19.59%,BCDIN3D;PRMT3;TRMT11;METTL27;CARNMT1;RRP8;NTMT1;COQ5;LCMT1;COQ3;NSUN2;FTSJ1
prerank,chemokine receptor binding (GO:0042379),0.26789097590059285,0.798579938674265,0.7698815566835872,1.0,1.0,2/35,8.51%,CXCL12;CCL25
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3327179416600047,0.7971010627262521,0.7373540856031129,1.0,1.0,4/12,15.70%,RUVBL2;RELA;TBP;TAF1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.3103671456596151,-0.795128887480655,0.7411273486430062,0.9177148090972128,1.0,7/14,45.89%,KCNJ2;KCNQ1;KCNJ3;KCNJ8;KCNIP2;KCNE4;KCNH2
prerank,cytokine receptor activity (GO:0004896),0.22904267635607842,0.7945599460947054,0.8204747774480712,1.0,1.0,4/83,3.15%,GFRA3;IL1R1;IFNLR1;CRLF1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3243721504659454,-0.7944004400483001,0.7393162393162394,0.9156984505275038,1.0,6/12,19.53%,CDK6;BRD4;CDK7;CCNK;CDK9;CDK12
prerank,pentosyltransferase activity (GO:0016763),0.2692782469718425,0.7941433966710896,0.7836456558773425,1.0,1.0,7/36,11.70%,UPP1;SIRT3;SIRT1;PARP11;UPP2;PNP;TNKS
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.2737542228045215,-0.7927111519043287,0.7838479809976246,0.9154524344325444,1.0,8/20,25.23%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,bHLH transcription factor binding (GO:0043425),0.3060898105745378,0.7924561427487286,0.7375886524822695,1.0,1.0,7/19,16.10%,USF2;SIRT1;LMO2;CREBBP;SP1;MAP3K10;TCF3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3578770532118968,0.7897541373738234,0.7435897435897436,1.0,1.0,5/10,18.84%,EP300;USP22;NAA50;MSL3;HAT1
prerank,telomeric DNA binding (GO:0042162),0.2686885084808759,0.7896252036603634,0.7646076794657763,1.0,1.0,5/32,10.59%,CTC1;SMG1;ACD;UPF2;TERT
prerank,serine-type peptidase activity (GO:0008236),0.22295277945288233,0.7878872959704231,0.8608695652173913,1.0,1.0,2/96,0.59%,PCSK1;CELA1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3302786844087372,-0.7866113874743207,0.7593360995850622,0.9217027607674058,1.0,9/11,66.99%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,ligand-gated cation channel activity (GO:0099094),-0.20841534805066975,-0.785845522991414,0.8689024390243902,0.9196772973777839,1.0,19/75,29.72%,GRIA4;GRIA2;GRIN2B;P2RX4;KCNJ2;KCNJ6;GRIK4;KCNJ13;KCNJ10;GRIK1;GRIK3;GRIN2D;GRIN1;MCOLN1;CHRNA7;GRIA1;KCNK1;KCNJ12;CCDC51
prerank,acetyltransferase activity (GO:0016407),0.27521247256015896,0.7858390589856807,0.7719869706840391,1.0,1.0,8/31,18.78%,ACAT1;EP300;ESCO1;CREBBP;NAA80;NAA15;ELP3;NAA50
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2653191954713994,0.7856370720357468,0.7979966611018364,1.0,1.0,7/34,14.43%,EZH2;TTLL12;SMYD3;SETD3;KMT5B;DOT1L;ETFBKMT
prerank,phosphate ion binding (GO:0042301),0.345378439921316,0.7810787811768279,0.7495145631067961,1.0,1.0,2/10,10.61%,RELA;PNP
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.269991396432687,0.7780556217200644,0.7781569965870307,1.0,1.0,3/30,6.20%,RPS6KA1;BIRC2;CARD16
prerank,nuclear export signal receptor activity (GO:0005049),0.33788330840057057,0.7760851041446333,0.7514677103718199,1.0,1.0,4/11,18.37%,XPO5;RANBP17;XPO1;NUP42
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.26941279948564445,0.7684404754659501,0.7923211169284468,1.0,1.0,4/29,11.64%,ACER2;ENGASE;MGAM;ACER3
prerank,inward rectifier potassium channel activity (GO:0005242),-0.25192906431656636,-0.7657410894044834,0.8056155507559395,0.9459682894840243,1.0,11/24,39.09%,KCNJ2;KCNJ6;ABCC9;KCNJ13;KCNJ10;KCNK1;KCNJ12;KCNJ3;KCNK6;KCNJ8;KCNJ15
prerank,phosphatase activity (GO:0016791),0.22499693231625748,0.7650146616172022,0.8880918220946915,1.0,1.0,12/73,13.32%,PTPRJ;ENOPH1;DUSP12;PLPP6;PXYLP1;PLPP1;PRUNE1;DUSP11;PGP;APTX;PTPMT1;PPP5C
prerank,RNA methyltransferase activity (GO:0008173),0.29021549940737024,0.7630574723989157,0.8014981273408239,1.0,1.0,1/19,2.25%,BCDIN3D
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.31286662833786083,-0.7627866680590342,0.7936842105263158,0.9471151030494064,1.0,4/12,16.42%,BACE2;BACE1;DDI2;HM13
prerank,sodium channel activity (GO:0005272),0.2516495826641077,0.7622995406900455,0.8148760330578513,1.0,1.0,3/37,4.61%,GRIK5;GRIK2;SCN2A
prerank,leucine zipper domain binding (GO:0043522),-0.32475821206716776,-0.7617661976126844,0.7736220472440944,0.9454174925674984,1.0,2/10,5.24%,PAWR;AATF
prerank,NADPH binding (GO:0070402),0.31322620054387296,0.7601687438497575,0.7695167286245354,1.0,1.0,2/13,8.84%,HMGCR;KCNAB1
prerank,chloride transmembrane transporter activity (GO:0015108),0.3091072964805677,0.7594436472847167,0.7473309608540926,1.0,1.0,2/16,9.01%,SLC1A1;CLCN7
prerank,BMP binding (GO:0036122),-0.31294389181533416,-0.7532587554797426,0.792,0.9538920515481251,1.0,3/11,19.93%,NBL1;GREM2;BMPR2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3285171105337973,0.753141193982181,0.7790697674418605,1.0,1.0,2/11,8.79%,LEF1;ZXDC
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3227505461925635,-0.7527508373318043,0.7936507936507936,0.951327755302283,1.0,2/10,12.80%,CXADR;SIRPA
prerank,phosphatidic acid binding (GO:0070300),-0.26377507313323545,-0.7519585252525668,0.85,0.9491194079550286,1.0,13/19,41.05%,GRAMD1B;SMPD3;PITPNC1;COMMD1;RAPGEF2;GSDMD;PLEKHN1;MICALL1;JPH2;MAPKAP1;OPA1;ATP13A2;PITPNM1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3035175193889408,-0.7518782900581334,0.8164948453608247,0.9460092145625474,1.0,3/13,5.78%,AGPAT4;ABHD5;AGPAT5
prerank,NADP binding (GO:0050661),0.25448389455377063,0.7516425995131888,0.8653530377668309,1.0,1.0,5/32,11.15%,SPR;ME3;HMGCR;KCNAB1;NOS3
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.33481743156053867,0.7516281238681427,0.7755905511811023,1.0,1.0,4/10,16.70%,SETD5;SETD3;NSD2;SETD2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.33155106921241373,0.7511155403097656,0.756007393715342,1.0,1.0,3/11,16.57%,SLC25A24;SLC25A42;SLC25A25
prerank,ferrous iron binding (GO:0008198),0.2827483867830056,0.750121454484515,0.8050541516245487,1.0,1.0,6/21,17.73%,ALKBH2;ISCU;EGLN2;FTO;TET2;FECH
prerank,NAD+ binding (GO:0070403),-0.29544348333275894,-0.7492390399191248,0.7917570498915402,0.9462505671138766,1.0,3/12,7.04%,ZC3HAV1;SIRT2;GLUD1
prerank,myosin II binding (GO:0045159),-0.3222882318082503,-0.7479742527567217,0.7835051546391752,0.9445822783246962,1.0,3/10,14.45%,GSN;STXBP5;TRIOBP
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3091438079250691,0.7451006392401427,0.7875939849624061,1.0,1.0,2/14,12.82%,NME1;DTYMK
prerank,MHC class II protein complex binding (GO:0023026),-0.31308160757586656,-0.7449404164390918,0.8281573498964804,0.9454122134586054,1.0,3/11,10.64%,ATP1B1;ANXA11;PKM
prerank,SH2 domain binding (GO:0042169),0.25750684685785974,0.7444364243901095,0.8505747126436781,1.0,1.0,6/31,14.56%,SRC;DAG1;TRPV4;NLK;PAG1;RUFY1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2756822831636029,0.7428715410297093,0.8141135972461274,1.0,1.0,3/22,8.81%,ILF3;ZFP36L1;EXOSC9
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.31532338133629434,0.7380836296079603,0.7911877394636015,1.0,1.0,3/12,10.95%,CIAPIN1;ISCU;CISD2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.28627258578579934,0.7377888001948834,0.7836363636363637,1.0,1.0,4/17,18.29%,PPT1;ACOT8;ACAA2;ACOT13
prerank,thioesterase binding (GO:0031996),0.31967478766007296,0.737574909574067,0.7804878048780488,1.0,1.0,3/11,15.57%,TRAF5;TRAF3;ARF6
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.27880618104932425,-0.7361340654433173,0.8169934640522876,0.9536022411659498,1.0,3/16,5.65%,SLC13A3;SLC1A5;SLC25A13
prerank,E-box binding (GO:0070888),0.24559408362062343,0.7354540523293079,0.8440065681444991,1.0,1.0,5/34,16.10%,TAL1;CLOCK;TFAP4;HES1;TCF3
prerank,methylation-dependent protein binding (GO:0140034),-0.20152652138982022,-0.735367860578152,0.9304347826086956,0.951383646024357,1.0,25/57,31.63%,MBTD1;KDM4A;KDM7A;MPHOSPH8;ZCWPW2;PYGO1;RBBP5;GLYR1;MTF2;SGF29;CBX5;SUZ12;BPTF;PHF2;KAT8;PHF1;L3MBTL2;ZMYND8;NCAPG2;WDR5;KDM8;MSH6;ING1;PHF13;LRWD1
prerank,snoRNA binding (GO:0030515),-0.23066267632164214,-0.7352383962090363,0.8903743315508021,0.9484173927225232,1.0,20/30,42.78%,NUDT4;BMS1;UTP6;DDX21;NOP56;NUFIP1;NOP14;WDR3;NUDT7;BYSL;IMP3;GAR1;IMP4;TSR1;DHX37;NOP10;NUDT1;TBL3;NUDT16;NUDT16L1
prerank,MHC class I protein binding (GO:0042288),0.30584968214365116,0.7340944478709592,0.8206106870229007,1.0,1.0,4/13,20.10%,TUBB;ATP5F1B;DERL1;TAP2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.31550888952903006,0.7340786141558657,0.7872340425531915,1.0,1.0,3/12,15.17%,GREM1;CDH5;VEGFC
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32954102394645257,0.7333615907419114,0.7928436911487758,0.9993696719838367,1.0,3/10,17.42%,DCLRE1B;EXD2;DCLRE1C
prerank,histone methyltransferase binding (GO:1990226),0.32593631144374025,0.733115246468968,0.7810077519379846,0.9964653946338367,1.0,3/11,15.79%,PRDM4;LCORL;WIZ
prerank,N-acetyltransferase activity (GO:0008080),0.28468610924940474,0.7306742748243432,0.8309608540925267,0.9965369134105635,1.0,3/19,12.78%,EP300;ESCO1;NAA80
prerank,receptor antagonist activity (GO:0048019),-0.2676529215620425,-0.7300666559429659,0.851063829787234,0.9514451080351146,1.0,1/17,7.08%,DKK3
prerank,Hsp70 protein binding (GO:0030544),-0.23144628713922652,-0.729497452399391,0.8721227621483376,0.9489426047979321,1.0,11/31,29.10%,PACRG;PPID;SACS;GPR37;DNAJC2;STUB1;DNAJB2;METTL21A;DNAJA1;PPEF2;SNCA
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.26685461050908577,-0.7269149372517703,0.8797327394209354,0.9488983580937109,1.0,9/17,35.87%,ABCA1;PITPNC1;ATP8B2;ATP8B1;MTTP;ABCA7;ABCB4;ATP10B;PCTP
prerank,cytochrome-c oxidase activity (GO:0004129),0.2904255634652136,0.7232708371615627,0.8211538461538461,1.0,1.0,4/15,14.41%,COX6B1;COX5A;COX15;COX10
prerank,receptor ligand activity (GO:0048018),0.18167294183873542,0.7214559271374964,0.9900744416873449,1.0,1.0,15/245,9.12%,GDF1;JAG2;SEMA6A;SEMA6D;SEMA7A;GREM1;CRLF1;GNRH1;SEMA3C;SEMA6B;BDNF;CCL25;WNT5A;NPPC;SEMA4C
prerank,methylated histone binding (GO:0035064),0.2211062608986027,0.7195729184032805,0.9074074074074074,1.0,1.0,18/62,19.14%,TTLL12;ING4;SPIN1;CDYL;ING3;ING2;CHD1;MORC4;TDRD3;RRP8;ING5;PHF8;TAF1;CHD8;MORC3;ATRX;MSL3;ZMYND11
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3070716821079882,0.7192571140901652,0.8403193612774451,0.9979641448608596,1.0,5/12,21.53%,TENT4A;PAPOLA;PAPOLG;TENT2;MTPAP
prerank,protein kinase inhibitor activity (GO:0004860),0.23621365333852135,0.7187031041393908,0.8856682769726248,0.9953836116388048,1.0,5/42,6.38%,RPTOR;SPRED1;CIB1;CDKN1A;YWHAB
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.28818014211531007,0.7171123513566747,0.8380782918149466,0.9942236465238625,1.0,4/16,12.22%,TDG;SMUG1;RPS3;ADPRH
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24122369373448901,0.7160209747940467,0.8782161234991424,0.9923823061934102,1.0,8/34,16.45%,UFC1;UBE2I;AKTIP;UBE2R2;UBE2F;UBE2G1;TAF1;UBE2H
prerank,proton transmembrane transporter activity (GO:0015078),-0.2106884625531652,-0.7147116860867545,0.9310344827586207,0.9590425249000414,1.0,17/39,33.95%,CYB5A;UQCRH;COX8A;CTNS;UQCRC1;NDUFA4;COX7A2L;COX6A1;SLC11A2;DMAC2L;UQCR10;UQCRQ;UQCR11;SLC9A1;NNT;COX5B;CLCN4
prerank,carbohydrate kinase activity (GO:0019200),-0.3024296440900711,-0.7138714606624662,0.8468085106382979,0.9569720924529119,1.0,7/11,48.50%,NAGK;HK2;GALK1;POMK;HK1;XYLB;KHK
prerank,"DNA binding, bending (GO:0008301)",-0.2702512116342297,-0.7068646014369167,0.865934065934066,0.9615778080735259,1.0,9/14,35.83%,FOXD1;FOXC1;SAP30L;FOXL1;HMGA2;TERF1;HMGB1;HHEX;HMGB2
prerank,nuclear import signal receptor activity (GO:0061608),-0.2678612010482334,-0.7051240966267467,0.8599137931034483,0.9602500581658432,1.0,3/15,12.91%,IPO9;TNPO3;TNPO2
prerank,endopeptidase activator activity (GO:0061133),0.3031306637280011,0.7044379018404602,0.8382642998027613,1.0,1.0,3/10,15.68%,VSIR;PSMD14;APH1A
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2613825524445751,0.7021490752713573,0.8660714285714286,1.0,1.0,5/20,14.32%,YOD1;DESI2;USP47;OTUD5;USP9X
prerank,DNA secondary structure binding (GO:0000217),-0.2194410144592797,-0.7018922749013051,0.9387254901960784,0.9604844279915873,1.0,16/31,36.90%,KMT2A;MAPT;ERCC5;LIN54;RAD51D;MSH2;XPC;BLM;MSH6;HMGA2;CLSPN;RAD51C;HMGB1;MEN1;HMGB2;XRCC2
prerank,lipid phosphatase activity (GO:0042577),0.2837094083185957,0.6990197797831949,0.8550185873605948,1.0,1.0,4/14,13.89%,PLPP6;PLPP1;SGPP2;SGPP1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.30354130317732647,0.6962175953348745,0.8361266294227188,1.0,1.0,1/12,1.88%,SLC25A24
prerank,endoribonuclease activity (GO:0004521),-0.21579690958588726,-0.6938308683937199,0.9386666666666666,0.9652759613940727,1.0,13/32,31.69%,AGO3;SND1;DICER1;INTS11;ZC3H12B;RCL1;NOB1;CPSF3;LACTB2;RIDA;ZC3H12A;EXOG;RNASEL
prerank,hormone activity (GO:0005179),0.2117015999670988,0.6910430222079561,0.935126582278481,1.0,1.0,4/54,10.60%,GNRH1;CCL25;NPPC;PPY
prerank,fatty acid synthase activity (GO:0004312),0.30277099680896413,0.6879494911922264,0.8759842519685039,1.0,1.0,1/10,5.49%,ELOVL6
prerank,carboxylic ester hydrolase activity (GO:0052689),0.19960957815799094,0.6841492063697865,0.949928469241774,1.0,1.0,9/85,15.11%,NDST3;CA2;PLAAT3;PNPLA7;PGLS;ABHD12;ABHD4;PNPLA6;DAGLB
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.27271193956572204,0.6834610382103385,0.8723809523809524,1.0,1.0,4/15,13.87%,LPCAT2;GPAT4;AGPAT3;ABHD4
prerank,cAMP binding (GO:0030552),0.29705753179718314,0.682085959955094,0.8530534351145038,1.0,1.0,1/11,1.75%,PDE4D
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3001933796614117,0.6812598870561763,0.8506616257088847,0.9983829227292603,1.0,4/11,20.86%,SGMS1;PIGN;SAMD8;SGMS2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.29633607136544954,-0.6812286734405264,0.8861283643892339,0.974245638480704,1.0,2/10,16.08%,CDADC1;LACC1
prerank,5'-3' exonuclease activity (GO:0008409),0.2813219943538911,0.6811521473994152,0.868421052631579,0.9954186834361007,1.0,3/14,9.41%,DCLRE1B;XRN2;DXO
prerank,low-density lipoprotein particle binding (GO:0030169),-0.2546847050492349,-0.6805299512271415,0.8701825557809331,0.9717647601375913,1.0,3/16,9.33%,SORL1;LDLR;THBS1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.25450665786576443,-0.6772851774142881,0.8859060402684564,0.9714281722526509,1.0,4/15,29.77%,P2RX4;P2RY14;P2RY12;P2RY1
prerank,phosphatase activator activity (GO:0019211),0.27971991560441534,0.6741059424221779,0.8670411985018727,0.9987101422684411,1.0,6/14,21.18%,CALM3;PPP2R5A;FRS2;CALM1;PPP2R5C;PHACTR4
prerank,actin monomer binding (GO:0003785),0.2523093561008139,0.6693586508170484,0.9075785582255084,0.9996837395865473,1.0,4/22,14.34%,MRTFA;PFN1;NOS3;TWF1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2652867288571168,-0.6680155149341374,0.9036697247706422,0.9761163568208753,1.0,3/13,20.12%,SLC7A2;SLC38A7;SLC15A4
prerank,lysophospholipase activity (GO:0004622),0.24602452260528407,0.6550875198055323,0.9095652173913044,1.0,1.0,6/20,20.30%,PNPLA7;ABHD12;ABHD4;PNPLA6;LYPLA1;ENPP2
prerank,phospholipase A2 activity (GO:0004623),-0.2142373076526911,-0.6537575991008325,0.9437652811735942,0.983856097195073,1.0,10/26,39.03%,PLA2G4A;ABHD3;PLA2G6;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PLA2G4E;PNPLA3;PLA2G4C
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.19713903572304226,0.6518435182466369,0.9745889387144993,1.0,1.0,10/60,16.13%,CTDSP1;PPP3CB;PPP2CA;PPP2CB;PHLPP1;PPP3CA;PPP3R1;PPP5C;CAMK2G;PPM1L
prerank,P-type ion transporter activity (GO:0015662),-0.26341739715437423,-0.6497718818988218,0.9225806451612903,0.9835585440805956,1.0,2/12,5.67%,ATP6V1E1;ATP7A
prerank,mRNA methyltransferase activity (GO:0008174),0.2811900454633416,0.6449996906456017,0.9052224371373307,1.0,1.0,4/12,20.13%,TRMT61B;RNMT;NSUN2;METTL14
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.2582777205919401,-0.6337524570817361,0.9118279569892473,0.9908012280099839,1.0,6/12,38.58%,GAB2;PIK3R1;SH2B1;BLNK;SH2B2;TRADD
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.276166566010041,-0.633158489446543,0.917004048582996,0.9880610494955866,1.0,2/10,5.28%,KDM4A;KDM7A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.20719619365825306,0.6303237408939365,0.964765100671141,1.0,1.0,7/40,13.07%,THUMPD2;CARNMT1;ICMT;SETD3;METTL2B;METTL2A;RRP8
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.27617373838814974,0.6296733595348948,0.912621359223301,1.0,1.0,11/11,72.40%,KCND3;KCNE1;KCNE3;KCNE2;KCNJ5;KCNE5;KCNH2;KCNE4;KCNJ8;KCNJ3;KCNQ1
prerank,RNA polymerase binding (GO:0070063),0.2399413910781448,0.6182629903105157,0.9292364990689013,1.0,1.0,7/18,21.38%,PPIB;STOM;SCAF8;TCERG1;YTHDC2;PKN2;DHX9
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.21195675566573985,-0.6167384844398337,0.9576837416481069,0.9943633365481689,1.0,2/21,10.73%,FGF1;KL
prerank,enoyl-CoA hydratase activity (GO:0004300),0.27525669813531556,0.6157839052222258,0.9139579349904398,1.0,1.0,5/10,22.43%,HSD17B4;ECHDC1;ECHS1;HADHA;AUH
prerank,transaminase activity (GO:0008483),-0.2565050877812968,-0.6124509941607689,0.934560327198364,0.9934915009169135,1.0,4/11,24.63%,ABAT;BCAT1;GOT1;OAT
prerank,sequence-specific mRNA binding (GO:1990825),0.26511014874788175,0.6094781730442065,0.9309021113243762,1.0,1.0,10/10,73.51%,SSB;DHX9;FMR1;LIN28A;LARP6;ETF1;RBM24;TYMS;DHFR;SHFL
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.2566188171279289,0.6081053157076357,0.9349112426035503,1.0,1.0,2/14,12.10%,ISCU;ACO1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.21714294600761902,-0.6044703102499608,0.962800875273523,0.994346688674349,1.0,14/19,54.26%,WRNIP1;MCM6;RFC2;HELQ;POLQ;DNA2;RFC3;RAD51;RFC4;MCM7;MCM5;DSCC1;CHTF18;PIF1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.1837561998407451,-0.6035697802110347,0.992462311557789,0.9916368111210703,1.0,21/35,44.14%,DUS2;ELAC1;TARS2;NT5C3A;MTFMT;QTRT2;DUS4L;QRSL1;PTRH2;QTRT1;TRMT5;LCMT2;DTWD1;DUS3L;ELAC2;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.26593997297912153,0.5919368072000999,0.9412878787878788,1.0,1.0,1/10,5.65%,CDKN1A
prerank,FMN binding (GO:0010181),-0.24183513016523656,-0.5860305236922704,0.9411764705882353,0.9964399123571294,1.0,5/11,36.00%,DUS2;MTRR;POR;NOS1;NDOR1
prerank,titin binding (GO:0031432),-0.23027057240906063,-0.5831447324239315,0.954639175257732,0.9945533769063181,1.0,2/13,10.68%,ACTN2;CAMK2D
prerank,nucleoside-diphosphatase activity (GO:0017110),0.24605729644266763,0.5801435438980227,0.9323308270676691,1.0,1.0,1/12,3.76%,NUDT5
prerank,endopeptidase regulator activity (GO:0061135),-0.17240499436711973,-0.5792651587650663,0.9907834101382489,0.9929378343479063,1.0,13/40,36.54%,TFPI;PSMF1;ITIH2;RENBP;CAST;SERPIND1;APH1B;PSME2;PSME3;ABCA2;PSME1;PSENEN;SPINT2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.2449362536945975,-0.5750773634571034,0.9533898305084746,0.9916482548353234,1.0,2/11,11.82%,PPP1R1A;PPP1R14C
prerank,antiporter activity (GO:0015297),0.21409443421566626,0.5645794112153157,0.9739776951672863,1.0,1.0,2/20,8.41%,CLCN3;SLC35A1
prerank,receptor tyrosine kinase binding (GO:0030971),0.1711804096307433,0.5579023169530026,0.9923430321592649,1.0,1.0,2/56,2.11%,CBL;MAP3K7
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.1841101471576258,0.5565729440107935,0.9886363636363636,1.0,1.0,13/38,21.11%,DENND1A;TECPR1;LANCL2;PARD3;PLEKHA5;ZFYVE1;SNX27;KIF16B;ZFYVE19;ZFYVE26;WDR45B;ATG2B;SNX12
prerank,histone acetyltransferase activity (GO:0004402),0.1960901460943513,0.555777137449249,0.9787234042553191,1.0,1.0,8/30,18.84%,EP300;CLOCK;CREBBP;USP22;TAF1;TADA2A;NAA50;HAT1
prerank,CARD domain binding (GO:0050700),0.2304394530893411,0.5543591661050589,0.9749518304431599,1.0,1.0,2/14,11.38%,CARD16;NOD1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.21625219198658177,0.5425429063895473,0.97632058287796,1.0,1.0,2/17,12.82%,NME1;DTYMK
prerank,four-way junction DNA binding (GO:0000400),0.21264846349421368,0.5399617885662122,0.972875226039783,1.0,1.0,2/17,10.81%,YY1;RAD51B
prerank,death domain binding (GO:0070513),0.23253066516429421,0.5343297362908815,0.9684418145956607,1.0,1.0,3/11,17.79%,CRADD;DAPL1;BAX
prerank,glucose transmembrane transporter activity (GO:0005355),0.21022227803591614,0.5305893293230848,0.9772329246935202,1.0,1.0,17/17,79.00%,SLC2A1;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC2A8;SLC5A11;SLC5A3;SLC2A10;SLC2A3;MFSD4A
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.2247818718222336,0.5220245415269773,0.9619047619047619,1.0,1.0,12/12,77.54%,NQO2;CRYZL1;ADH4;AKR1C1;DCXR;NQO1;CBR1;CRYZ;NDUFS7;CBR4;AIFM2;DHRS4
prerank,hyaluronic acid binding (GO:0005540),-0.22291289242354365,-0.5217863083078784,0.9764705882352941,1.0,1.0,1/10,4.65%,CEMIP
prerank,ribonuclease P activity (GO:0004526),-0.21161607381769162,-0.5078695392971982,0.9788583509513742,1.0,1.0,6/11,41.09%,PRORP;RPP30;RPP14;RPP21;POP4;RPP38
prerank,5'-nucleotidase activity (GO:0008253),0.21350791342129288,0.5061162621426041,0.9727095516569201,1.0,1.0,3/13,18.68%,NT5C3B;NT5C2;NT5DC1
prerank,lipase activity (GO:0016298),0.1653020022870114,0.5016414344030722,0.9950657894736842,1.0,1.0,5/43,15.11%,SEC23IP;DDHD1;PNPLA8;ABHD12;DAGLB
prerank,neuropeptide receptor binding (GO:0071855),0.19800364115763683,0.4880667922008753,0.9831460674157303,1.0,1.0,14/14,80.22%,PPY;AGRP;APELA;UCN3;QRFP;GHRH;NPPA;UCN2;GAL;APLN;NPY;NTS;NMU;SHANK1
prerank,hexose transmembrane transporter activity (GO:0015149),0.21015629903960842,0.47793824522519074,0.9866920152091255,1.0,1.0,12/12,79.00%,SLC2A1;SLC2A7;SLC5A1;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC2A8;SLC5A3;SLC2A3;MFSD4A
prerank,ribonuclease P RNA binding (GO:0033204),0.2089374254691521,0.46975246715998514,0.9807692307692307,1.0,1.0,10/10,79.12%,POP5;POP1;RPP25;RPP40;POP7;RPP38;POP4;RPP21;RPP14;RPP30
prerank,peptidoglycan binding (GO:0042834),0.19619657315006583,0.44012210280786285,0.9941520467836257,1.0,1.0,10/10,80.39%,NOD1;PGLYRP2;PGLYRP3;TLR2;NLRP3;JCHAIN;NOD2;HK1;PGLYRP1;RNASE7
prerank,growth factor activity (GO:0008083),0.1257644416708129,0.43215045373983546,1.0,1.0,1.0,1/74,0.86%,JAG2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.16415314084964272,-0.42611631254810656,0.9936708860759493,1.0,1.0,7/14,41.09%,PRORP;RPP30;RPP14;RPP21;ELAC2;POP4;RPP38
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.17714805432846295,-0.4106318152284669,0.9978213507625272,1.0,1.0,1/10,11.53%,NOX4
prerank,nucleotidase activity (GO:0008252),0.16002114846538612,0.3925136393260103,1.0,1.0,1.0,2/15,12.02%,NT5C3B;NT5C2
prerank,CoA hydrolase activity (GO:0016289),-0.1458280493773563,-0.3865989018409521,1.0,1.0,1.0,3/16,24.07%,ACOT11;ACOT7;NUDT7
prerank,pseudouridine synthase activity (GO:0009982),-0.1519657933412284,-0.38218702351776784,1.0,0.9996261814078149,1.0,10/13,51.67%,PUS7;TRUB1;PUS3;RPUSD4;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,acylglycerol lipase activity (GO:0047372),0.16331910620135576,0.3669582755629454,1.0,0.9996441193795406,1.0,11/11,83.68%,ABHD12;ABHD16A;PNLIPRP2;ABHD12B;ABHD6;ABHD2;ABHD15;MGLL;FAAH;LIPE;ABHD3
